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ABSTRACT
A series of experiments were designed to determine the cyclooxygenase (COX) 
isoform responsible for prostaglandin release during ovulation and luteolysis. Initially, 
a reliable, serum-free culture system was developed to produce large numbers of bovine 
granulosa cells originally harvested from the small antral follicles of abattoir ovaries. 
This method allowed adequate numbers of cells to be obtained for the subsequent study 
involving cyclooxygenase regulation.
In a second experiment, bovine granulosa cells from small antral follicles were 
isolated and cultured, as in the first experiment for 6 days. Granulosa cells were then 
exposed to medium alone or medium containing arachidonic acid (10 nM arachidonic 
acid) or forskolin (10 uM). Bovine granulosa cells were capable of being induced into 
secreting elevated concentrations of prostaglandins following exposure to forskolin, in 
a manner similar to preovulatory granulosa cells stimulated in vivo. Prostaglandin 
formation was inhibited by the addition of hydrocorticosterone to the medium, 
implicating the COX-2 isoform as being responsible for this prostaglandin formation. 
Also, data from a third experiment revealed the presence of COX-2 in the granulosa 
cells of women previously stimulated with FSH.
A fourth experiment was performed to determine if dexamethasone regulates COX 
formation in the bovine uterus during luteolysis. Plasma estradiol concentrations 
indicated that daily administration of dexamethasone (days 13-22) during the estrous cycle 
resulted in an inhibition of follicle development. Although luteal regression occurred at
xi
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the normal time in these animals, uterine biopsies on days 16, 19 and 22 of the cycle and 
western blot analysis revealed that COX-2 was not produced by the uterine endometrium
at any of these times.
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INTRODUCTION
It is astonishing to reflect upon the accuracy of early reports involving 
mammalian reproductive processes. It has been over 70 years since the first reports 
implicated the uterus in luteolysis. After determining that hysterectomizing guinea pigs 
resulted in an extension of the estrous cycle, Loeb (1927) concluded "it is possible that 
the uterus, in particular its mucosa, produces an internal secretion which exerts a 
specific, abbreviating effect on the life of the corpus luteum". Since this earlier report, 
the uterus has been shown to regulate the functional lifespan of the corpus luteum in 
common farm animal species including the pig (Moeljono et al., 1976), the sheep 
(Wiltbank, 1966) and the cow (Malven and Hansel, 1964).
Today, it is accepted by most that the luteolytic hormone in ruminants is 
prostaglandin F2a. It is also accepted that luteolysis is a local process, involving the 
veno arterial transfer of prostaglandin from uterine vein to the ovarian artery (Hixon 
and Hansel, 1974). The mechanism by which uterine prostaglandin travels to the ovary 
has been termed the luteolytic counter-current transfer (McCracken et al., 1972). 
However, the manner in which prostaglandin F2a induces luteolysis, once traversed to 
the corpus luteum, remains controversial (Goldberg and Ramwell, 1975; Hansel and 
Convey, 1983).
The scope of prostaglandin study has broadened from the initial studies on its 
role as a luteolysin to other reproductive processes. Although not fully understood, the 
mechanisms by which prostaglandins induce ovulation are currently undergoing intense
1
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scrutiny. Espey (1980) hypothesized a general model for mammalian ovulation that 
included the accumulation of prostaglandins in the follicular fluid of preovulatory 
follicles. The process of ovulation was compared to that of inflammation, where 
prostaglandins were believed to perform many of the same actions. Some of these 
actions include activating quiescent fibroblasts, serine proteases and collagenase, 
causing an overt destruction of the follicle wall.
The enzyme responsible for the majority of prostaglandin production is the 
cyclooxygenase (COX) enzyme (Sigal, 1991). It is a rate limiting step in the formation 
of all types of prostaglandins, including prostaglandins I2 and F2a, or those familiar 
to scientists in the field of reproductive physiology. Recently, research has unveiled 
a new isoform of the COX enzyme (Rosen et al., 1989). The original isoform (COX-1) 
and the newly discovered isoform (COX-2), perform different biological functions that 
will be discussed in detail later in this review. Also, the COX-2 isozyme is inducible 
and is regulated differently than the original isoform first isolated from sheep vesicular 
glands (Miyamoto et al., 1976). The two major classifications of cyclooxygenase 
regulatory agents are those of nonsteroidal and steroidal origin, with each having 
distinct actions on either isoform.
The studies reported herein were undertaken at the St. Gabriel Louisiana State 
University Agricultural Research Station and at The Pennington Biomedical Center in 
Baton Rouge, Louisiana. The experiments were conducted 1) to determine the 
feasibility of producing an in vitro bovine granulosa cell serum-free culture system to
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
better understand COX activity in these cells, 2) to determine the effects of 
dexamethasone on prostaglandin formation by in vitro-cultured bovine granulosa cells 
and 3) to determine the origin and function COX-2 during the luteolytic process in 
cattle.
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LITERATURE REVIEW
The discovery of a novel COX isoform raised many questions regarding its 
function and regulation. The COX-2 isozyme, which is capable of producing large 
amounts of prostaglandin upon stimulation (Dewitt et al., 1993), has become an object 
of interest to scientists involved in the field of reproductive physiology. Some of the 
characteristics of the COX-2 isozyme suggest its involvement in reproductive processes, 
such as ovulation and luteolysis, both of which require the rapid elevation of 
prostaglandin formation.
This review will be directed toward understanding prostaglandin synthesis, and 
the function of prostaglandins in the ovulatory process. The regulation of each COX 
isoform will also be discussed, with the major emphasis on steroidal regulation of the 
COX isozymes. Finally, the effects of glucocorticoid administration to laboratory and 
large animals on estrous cycle events will be reviewed.
Arachidonic Acid Metabolism and Prostaglandin Formation
In the early 1930s, it was noted that human semen and seminal vesicle extracts 
caused uterine tissue to contract and relax (Hadley, 1992). This active purified 
substance, prostaglandin, was subsequently isolated from sheep vesicular glands in the 
mid 1970s (Miyamoto et al., 1976). Prostaglandins belong to the ecosanoid family of 
chemically related substances that also includes: leukotrienes, prostacyclin and 
thromboxane (Toh et al., 1992). Since this initial discovery, prostaglandins have been 
shown to be intricately involved in a number of biological processes. Some of these
4
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processes include tissue remodeling (Cromwell, 1988; Zurier, 1988), vascular 
homeostasis (Weksler et al., 1982), immune cell function (Jonat et al., 1990) and 
reproduction (Hixon and Hansel, 1974; Sirois et al., 1992).
The metabolic process from which prostaglandins are derived has been termed 
the "arachidonic acid cascade" (Toh et al., 1992). All prostaglandins are variants of 
a basic 20-carbon, bilayared molecule (arachidonic acid). This 20-carbon fatty acid is 
made available to the organism as a component of the diet (nonruminants) or 
synthesized in the liver from linoleic acid (ruminants) and stored in the cells as a 
component of the phospholipid bilayer of the cell membrane. In order to become 
available to the cell for metabolism, arachidonic acid must be freed from the cell 
membrane by the enzyme phospholipase A2, after which it is then converted to 
prostaglandins via the COX enzyme (Sigal, 1991).
Although two major routes of arachidonic acid metabolism have been defined, 
the COX and lipoxygenase pathways (Murdoch et al., 1993), this discussion will be 
concerned only with the COX pathway that involves prostaglandin formation. Figure 
1 illustrates an overview of arachidonic acid metabolism. The COX enzyme performs 
two functions in the conversion of arachidonic acid to prostaglandin (Sigal, 1991). 
Once arachidonic acid is liberated from the cell membrane, COX initially performs an 
oxidative function by introducing two molecules of oxygen to form Prostaglandin G2. 
Prostaglandin G2 then undergoes a reduction, or peroxidase reaction, to form 
prostaglandin H2.
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Figure 1. A schematic drawing of arachidonic acid metabolism to prostaglandin (adapted from Sigal, 1991)
CT\
From this point, prostaglandin H2 is further reduced to other metabolites that are more 
familiar in the study of reproductive physiology, including prostaglandin EU, I2 and F2« 
(Sigal, 1991).
Recent Discoveries in COX Metabolism
Until the late 1980s, it was assumed that there was only one gene encoding the 
COX enzyme (DeWitt and Smith, 1988). The COX enzyme was first isolated from 
sheep vesicular glands, and has been the focus of many of the prostaglandin regulatory 
studies conducted during the past 15 years (Miyamoto et al., 1976; Hedin et al., 1987). 
This original isoform, termed COX-1 in the scientific literature, is translated from a 2.8 
kb mRNA transcript and has a mw of 69,000 and 70,000 in the mouse (Hedin et al., 
1987) and bovine species (Sirois, 1994), respectively. Also, the primary structure of 
the COX-1 enzyme (8,11,14-icosatrienoate, hydrogen-donor:oxygen oxidoreductase, 
EC 1.14.99.1) has been reported (DeWitt and Smith, 1988). However, recent studies 
have established the presence of another pharmacologically distinct, but related, isoform 
of the original COX enzyme (Kujubu et al., 1987; Rosen et al., 1989).
Rosen et al. (1989) described the transcription of a novel cyclooxygenase 
isoform by in vitro-cultured sheep tracheal mucosal cells. A 70,000 mw cyclo­
oxygenase protein and corresponding 2.8 kb mRNA were coordinately expressed, but 
the levels did not increase proportionately to the increase in COX activity. However, 
rehybridization of Northern blots revealed the presence of a new tissue-specific 4.0 kb 
mRNA that exhibited increased expression during in vitro culture. The authors
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
suggested that the novel protein's relatedness to COX and its increased parallel 
enzymatic activity further suggest that the larger mRNA may encode for a second COX 
protein.
Recent reports have provided direct evidence of the existence of a distinct COX 
isoform that is derived from a unique mRNA transcript (Kujubu et al., 1991). It has 
been noted that the gene encoding the COX-2 isoform is the US 10 primary response 
gene (Kujubu et al., 1991), which has been cloned (O'Bannion et al., 1992). This gene 
was the first primary response gene for which cell-type restricted expression has been 
reported (Kujubu et al., 1987). Cyclooxygenase-2 mRNA production was initially 
reported to occur following forskolin stimulation of Swiss 3T3 cells that were 
previously transfected with the TIS10 gene (Kujubu et al., 1991). This second COX 
isoform is translated from a 4.0 kb mRNA and has a molecular weight of 72,000 to
74,000 (Sirois and Richards, 1992).
Although pharmacologically distinct, the COX-1 and -2 isoforms have a 
homology of greater than 60% to one another (Kujubu et al., 1991). More importantly, 
the amino acid residues believed to be important for catalysis are identical, and each 
isoform has the same affinity for and capacity to convert arachidonic acid to 
prostaglandin H2. One major difference between the two isozymes appears to be their 
dissimilar expression.
The proposed biological roles of each COX isoform have been compiled (see 
review by DeWitt et al., 1993) and are presented in Table 1. The COX-1 isoform is
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
a constituetively expressed enzyme that is present in most mammalian cells, although 
the level of expression does vary between cell types (Kujubu et al., 1991). In contrast, 
COX-2 is undetectable in most tissues under normal physiological conditions, but its 
expression can dramatically increase during periods of inflammation or mitogenic 
stimulation (Kujubu et al., 1993). Many mammalian cell types can be stimulated to 
produce the COX-2 isozyme by a variety of compounds including serum (Mitchell and 
Trautman, 1993), lippopolysaccharide (Lee et al., 1992), human chorionic 
gonadotropin (hCG; Sirois and Richards, 1992; Sirois et al., 1992; Sirois, 1994), 
platelet-derived growth factor (O'Bannion et al., 1992) and forskolin and phorbol esters 
(Kujubu et al., 1991).
Another notable difference in the characterization of the two COX isoforms is 
their reaction kinetics. Because the COX-1 isoform is constituetively expressed in most 
tissues, it has been termed a "housekeeping gene product" that regulates normal cellular 
processes, such as kidney function and vascular homeostasis (Jonat et al., 1990). 
Conversely, COX-2 has been grouped in the immediate early gene family, by virtue of 
its ability to rapidly produce high concentrations of prostaglandins during situations 
such as inflammation (Ryseck et al., 1992) and ovulation (Sirois and Richards, 1992; 
Sirois, 1994). This characteristic differentiates the COX-2 isoform from the original 
COX-1 cyclooxygenase enzyme. The COX-2 isoform has been determined to increase 
prostaglandin formation as much as 10- to 80-fold following stimulation (Simonson et 
al., 1991).
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Table 1. A compilation of characteristics assigned to the COX-1 and -2 isozymes including: homology, expression, range of 
expression, tissue expression regulation and proposed biological activity._________________________________________
Parameter COX-1 COX-2
Homology Similar to COX-2 (>60%) Similar to COX-1 (>60%)
Expression Constitutive Inducible
Range of expression Can increase 2 to 4 fold 
following stimulation
Can increase 10 to 80 fold 
following stimulation
Major tissues expressing 
each isoform Platelets, endothelial cells, 
fibroblasts, stomach, 
kidneys, smooth muscle 
most tissues
Prostate, brain, activated monocytes or 
synoviotes during inflammation, follicles 
preceding ovulation
Effect of 
glucocorticoids Little to none Inhibits expression
Proposed role of 
enzyme "Housekeeping" gene; produces 
prostaglandins that regulate normal 
kidney and gastric function and 
vascular homeostasis
"Inflammatory response gene"; produces 
prostaglandins involved in inflammation 
"Immediate early gene"; controls 
mitogenesis, produces prostaglandins 
involved in cell growth and ovulation
(adapted from DeWitt et al., 1993)
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The rapid generation and degradation of the COX-2 isozyme within a tissue 
makes it a logical candidate for being the paracrine factor that allows adjacent cells to 
relay information to each other (Murdoch et al., 1993). The rapid activation of genes 
whose products (COX-1 and -2) are responsible for prostaglandin synthesis in 
endotoxin-stimulated macrophages (Lee et al., 1992), may represent an important 
mechanism by which stimulated cells signal their neighbors of their impending division. 
This mechanism lends credence to the hypothesis that prostaglandin accumulation in 
preovulatory follicles is responsible for the cascade of events that occur following the 
rapid activation of quiescent fibroblasts. This process ultimately culminates in 
ovulation, and release of the oocyte from the dominant follicle into the oviduct for 
fertilization (Espey, 1980).
In summary, the COX enzyme plays an essential role in the conversion of 
arachidonic acid to prostaglandin in the process known as the "arachidonic acid 
cascade". This enzyme is essential to prostaglandin formation, and performs rate 
limiting actions in the conversion of arachidonic acid to prostaglandin G2 and H2. In 
turn, these prostaglandins are converted to other isoforms. It has been determined that 
two isoforms of the COX enzyme exist (Kujubu et al., 1991). Both isoforms are 
produced by a variety of tissues in the body; however, each isoform performs different 
biological functions. With the general function of each isoform fairly well defined, 
understanding the regulatory mechanisms of each isoform has now become the focus 
of research efforts.
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Induction of COX Activity During Mammalian Ovulation
Until now, this review has focused on COX-2 formation during inflammation. 
Recent studies have implicated prostaglandins in mammalian ovulation, which has 
previously been compared with an inflammatory response (Espey, 1980). This 
hypothesis has recently been updated (Espey, 1994). This basic model for ovulation 
in mammals is summarized in Figure 2. Breifly, prostaglandins are responsible for 
activating quiescent fibroblasts, which then activate serine proteases. Collagenase is 
then believed to be responsible for the degradation of the collagen fibres in the 
preovulatory follicle wall, resulting in ovulation. This process was hypothesized to be 
triggered by the preovulatory surge in LH.
The LH surge has since been shown to induce COX activity in rat preovulatory 
follicles (Hedin et al., 1987). A 72,000 mw COX protein was induced by mural 
granulosa cells following human chorionic gonadotropin (hCG) administration. The 
protein was produced by mural granulosa cells of preovulatory follicles 5 to 7 hours 
following exogenous administration of 10 IU hCG. Its production was shown to 
continue in increasing amounts until the time of expected ovulation. However, rat 
corpora lutea isolated 24 hours following hCG administration did not contain this novel
72,000 mw protein. Although the molecular weight of this COX enzyme was greater 
than that noted to be the case of the original rat isoform (72,000 vs. 70,000 mw, 
respectively), no mention of the possibility of this being a novel isoform was made in 
the latter study (Hedin et al., 1987).
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Figure 2. A schematic presentation summarizing prostaglandin activity 
during mammalian ovulation (adapted from Espey, 1980).
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Building on these data, an in vivo and in vitro study performed by Sirois et al. 
(1992) described the presence of the novel COX mRNA in rat preovulatory follicles. 
For the in vivo portion of the study, hypophysectomized, immature female rats were 
administered estradiol-176 (1.5 mg/day for 3 days) and FSH (1 for 2 days). Follicles 
were isolated from donor ovaries each hour for 11 hours following administration of 
an ovulatory dose of hCG. A similar experiment was performed in vitro, with donor 
follicles collected immediately following hCG administration, which were later 
evaluated for COX-2 mRNA and protein production during the same time frame as the 
in vivo portion of the study.
Results from the Northern blot analysis indicated that the COX-2 isoform is 
induced by hCG. Production of the 4.4 kb mRNA that translates the COX-2 isoform 
was noted to be rapid and transient, with concentrations increasing from an undetectable 
level at 0 hour and reaching maximal concentrations 4 hours post hCG stimulation. 
Levels of COX-2 mRNA were again undetectable at the 6 through 11 hour sampling 
periods. Western blot analysis, using an antibody which recognizes both isoforms, 
demonstrated that the actual COX-2 protein was translated 4 hours following in vivo 
administration of hCG and was continually produced throughout the sampling period. 
A similar trend in COX-2 mRNA and protein production was noted in the in vitro study 
(Sirois et al., 1992).
A study performed by the same authors was designed to determine the follicle 
cell type responsible for producing the COX-2 isoform (Sirois and Richards, 1992).
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Follicles were harvested from hypophysectomized rats that were estrogen primed as 
previously described (Sirois et al., 1992). The follicles were then dissected to isolate 
the granulosa cell layer from the rest of the follicle tissue. Western blot analysis 
indicated that the COX-2 isoform was selectively induced in granulosa cells, while 
being absent in residual follicle tissue, which included the membrane granulosa and 
theca cells. Also, a 59,000 mw gel band was reported, and assumed to be a breakdown 
product of the COX-2 isoform.
The most recently published study pertaining to COX-2 production in 
preovulatory follicles was performed in cattle (Sirois, 1994). Holstein heifers were 
administered 25 mg of prostaglandin F2a on day 7 of the estrous cycle to induce corpus 
luteum regression. An ovulatory dose of hCG (3,000 IU) was administered 36 hours 
following the prostaglandin injection. Ovaries were collected at 6 hour intervals for 18 
hours, then every 2 hours until 26 hours post-hCG injection. The cells of whole 
preovulatory follicles produced COX-2 beginning at 20 hours post-hCG. Following 
isolation of granulosa cells and theca interna cells from the follicle, it was found that 
COX-2 was exclusively produced in granulosa cells. No detectable levels of COX-2 
were produced by the theca interna cells. Also, increasing concentrations of 
prostaglandin F2a were released into the follicular fluid 22 through 26 hours following 
hCG administration.
The purification and identification of COX-2 in hCG induced rat and bovine 
follicles represents an important step toward understanding the role of prostaglandins
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in the biological process of ovulation. The selective localization of COX-2 in the 
granulosa cells of preovulatory follicles and its transient expression following the 
LH/hCG surge, indicate that the regulation of COX-2 is under stringent transcriptional 
control. Moreover, the acute induction of COX-2 by gonadotropins in granulosa cells 
before ovulation is a unique biological event, which may allow molecular mechanisms 
of COX-2 to be studied in vivo and in vitro.
Differential Regulation of COX Metabolism 
The understanding of COX regulatory mechanisms has improved since the 
discovery of the novel COX isoform. It is now known that certain compounds are 
capable of specifically inhibiting catalysis of arachidonic acid by either or both 
isoforms. These regulatory agents have been subdivided into two major groups 
including nonsteroidal and steroidal inhibitors of COX formation ( Dewitt et al., 1993). 
A variety of nonsteroidal anti-inflammatory agents have been researched, while the 
major steroidal agent investigated to date has been cortisol and related synthetics 
(Mitchell and Trautman, 1993).
Nonsteroidal Regulation
The oxidative function of COX is the target site of aspirin and other non­
steroidal anti-inflammatory drugs (NSALD), which are considered to be competitive 
inhibitors of COX-1 (Vane, 1971). DeWitt and Smith (1988) have demonstrated that 
aspirin inhibits the oxidative function of COX via irreversible acetylation of the "active 
site" serine residue at position 530. Mizuno et al. (1982) compared the effects of
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various anti-inflammatory drugs on the oxidative and peroxidase activity of the COX 
enzyme. It was determined that several NSAID including: aspirin, indomethacin, 
flurbiprofen and sulindac sulfide inhibited the oxidative activity of COX. However, 
other nonsteroidal agents, such as phenylbutazone and BW755c have been shown to 
inhibit the peroxidase activity of COX.
Meade et al. (1993) designed an experiment to determine if NSAID inhibit 
COX-2 production, and to determine if these agents possess any selectivity towards one 
specific isozyme. Cos-1 cells were transfected with cDNA for both COX-1 and-2 and 
incubated in medium with or without indomethacin or aspirin. Results of this study 
indicated that both aspirin and indomethacin specifically inhibited COX-1 activity, 
without affecting the production of COX-2.
Further investigation into NSAID has revealed preferential selectivity between 
the COX-1 and -2 isozymes (Meade, 1992). As earlier reported (Meade et al., 1993), 
sulindac sulfide specifically inhibited COX-1 production by Cos-1 transfected cells. 
However, the NSAID 6-methoxy-2-naphthylacetic acid, selectively inhibited COX-2 
production. Another NSAID ibuprofen was found to inhibit both isoforms equally.
In summary, NSAID are capable of selectively inhibiting either or both of the 
COX isoforms. In the future, it is possible that in vivo administration of NSAID that 
are capable of selectively inhibiting COX-2 production, may be found to spare the 
"housekeeping" activity of somatic cells, while reducing inflammation. Since COX-2 
is the isozyme responsible for prostaglandin formation in the preovulatory follicle, it
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is also interesting to speculate the possible role these NSAID could play as a method 
of birth control.
Steroidal Regulation
Since initial reports focused on the original COX isoform, hormonal regulatory 
studies involving glucocorticoids were often contradictory. Dexamethasone (9-flouro- 
11, 17, 21-trihydroxy-16 -methylpregna-1, 4-diene-3, 20-dione), is a synthetic corti­
costeroid that has been utilized in many COX regulatory studies, provides very potent 
glucocorticoid effects in vivo and in vitro. Dexamethasone is similar in structure to 
endogenously produced glucocorticoids and, in fact, is produced by modification of 
cortisol (Asdell, 1978).
Prior to the characterization of the COX-2 isoform, in vitro studies indicated 
that dexamethasone restricted COX formation by inhibiting phospholipase A2, resulting 
in a decrease in amount of available arachidonic acid (DiRosa et al., 1984). This idea 
was supported by Nasjletti et al. (1984) who noted a decrease in prostaglandin secretion 
by rat brain medullary slices that were cultured in medium supplemented with dexam­
ethasone. In contrast, when arachidonic acid was added to dexamethasone-supplement- 
ed culture medium, prostaglandin secretion was not decreased. These results led the 
authors to believe that dexamethasone had decreased prostaglandin formation by 
inhibiting phospholipase A2 activity, and subsequent arachidonic acid release from the 
cell membrane. However, later studies have challenged the idea that dexamethasone
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inhibits prostaglandin formation at the phospholipase A2 level (Davidson et al., 1987; 
Bronnegard et al., 1988).
Although prostaglandins and corticosteroids are known to be active participants 
in the inflammatory response, in vivo studies indicated that dexamethasone had no in 
vivo inhibitory effects on systemic prostaglandin synthesis (Lewis and Piper, 1975; 
Nara-Fejes-Toth et al., 1984). Nasjletti et al. (1984) designed an in vivo experiment 
to determine the effects of dexamethasone on urinary excretion and plasma 
concentrations of prostaglandins. It was noted that rats administered subcutaneous 
injections of dexamethasone did not have reduced concentrations of prostaglandins in 
either plasma or urinary excretions. Some experimental animals actually excreted 
higher concentrations of prostaglandins in plasma when compared with saline-treated 
controls; however, this phenomenon was attributed to a decrease in metabolism rather 
than a physiological effect on prostaglandin metabolism.
Nara-Fejes-Toth et al. (1984) reported total body and renal prostaglandin 
content following dexamethasone administration by measuring excretory prostaglandin 
metabolites. Under normal physiological restraints, rabbits were fed either water alone 
cr water containing dexamethasone (1 mg/kg per day) for 7 days, and the urinary 
excretions were collected. The administration of dexamethasone failed to cause a 
decrease in urinary prostaglandin metabolite production when compared with animals 
in the control group. The authors hypothesized this lack in response may be due to the
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fact that the dose of dexamethasone administered was not high enough to provide a 
physiological affect.
Interestingly, the authors did note in their discussion that the majority of studies 
that were performed to this date that implicated dexamethasone in prostaglandin 
inhibition all utilized cells that were stimulated by endotoxins (Blackwell et al., 1980; 
Hirata et al., 1980) or injury (Danon and Assouline, 1978). The hypothesis that 
dexamethasone regulates prostaglandin production only in stimulated cells launched a 
series of experiments involving COX regulation by dexamethasone during the 
inflammatory process.
In retrospect, Masferrer et al. (1990) may have unknowingly published one of 
the first reports in the scientific literature involving dexamethasone inhibition of COX-2 
catalysis. Male Balb-C mice were divided into one of four groups receiving 
intravenous saline, endotoxin (lipopolysacharride, LPS), endotoxin plus dexamethasone 
or dexamethasone alone. Peritoneal macrophages were harvested from the mice and 
allowed to attach to a 24-well tissue culture plate. It was noted that macrophages 
harvested from mice treated with LPS secreted increased levels of prostaglandin Ej and 
the prostaglandin I2 metabolite (6-keto PGF,a) when compared with control animals 
that received only saline. When LPS and dexamethasone were injected simultaneously, 
prostaglandin secretion decreased to control levels. Dexamethasone administration 
alone did not affect prostaglandin secretion above or below that of the control 
concentrations.
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Still with the knowledge of the existence of only one COX isoform, Masferrer 
et al. (1992) performed a classic endocrine study in an attempt to determine the 
mechanics of COX regulation by dexamethasone. In order to remove any endogenous 
glucocorticoid effect, peritoneal macrophages of adrenalectomized (ADX) mice were 
cultured for 2 hours following in vivo administration of saline, LPS, dexamethasone 
or LPS plus dexamethasone. Prostaglandin production (6-keto-PGFIa and PGEj) by 
the macrophages of ADX mice increased when LPS was administered. As previously 
described by Masferrer et al. (1990), in intact mice dexamethasone decreased prosta­
glandin formation to control levels. Prostaglandin secretion was also decreased to 
control levels following in vitro culture of macrophages simultaneously stimulated with 
LPS and dexamethasone.
A similar trend was noted in the production of a protein (COX) with an 
approximate molecular weight of 70,000 to 72,000 by LPS-stimulated mouse macro­
phages (Masferrer et al., 1990, 1992). Western blot analysis of macrophages harvested 
from LPS stimulated intact (Masferrer et al., 1990) or ADX (Masferrer et al., 1992) 
mice indicated the production of COX to be greater than from macrophages retrieved 
from control (unstimulated) mice. As with prostaglandin production itself, 
dexamethasone decreased this LPS stimulation of COX to levels similar to macrophages 
harvested from control mice. Since the initial report by Masferrer et al. (1990), 
dexamethasone has been shown to inhibit COX activity in other biological tissues 
including human dermal cells (Seibert et al., 1990), bronchial alveolar macrophages
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(O'Sullivan et al., 1993), bovine placenta (Izhar et al., 1992) and mouse uterine stroma 
(Jacobs et al., 1994).
Although the COX-2 isoform was not specifically characterized as such in the 
studies reviewed so far, it may now be extrapolated from existing data (Masferrer et 
al., 1990, 1992) that the decrease in prostaglandin secretion by stimulated mouse 
peritoneal macrophages may have actually been a result of the inhibition of COX-2 
catalysis. This conclusion may be reached on the basis of the differing kinetics of the 
two isoforms. It is now realized that the COX-2 isoform is activated only upon 
stimulation, and is able to produce levels of prostaglandins 10 to 80 times greater than 
the COX-1 isoform. Also, these studies indicated that the molecular weight of the 
COX isozyme noted in stimulated cells of all species evaluated to date is larger than the 
original COX-1 isozyme, which is characteristic of the COX-2 isozyme (Sirois et al., 
1992).
It was not until the early 1990s that the dispute over COX regulation by 
dexamethasone was resolved. With identification of the amino acid sequence of COX-2 
(Kujubu et al., 1991), Lee et al., 1992 prepared antibody specific to COX-2 by 
injecting rabbits with a conjugated amino acid sequence specific to the mouse COX-2 
carboxyl terminus. A second polyclonal antibody was prepared against purified ram 
seminal vesicle cyclooxygenase. This polyclonal antibody recognized both the COX-1 
and COX-2 isoforms, but possessed a preferential affinity for COX-1.
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The antibody specific for COX-2 did not detect COX in ram seminal vesicles 
extracts, indicating the majority of COX present was COX-1 (Lee et al.. 1992). An 
in vitro comparison of COX-1 and COX-2 by western blot analysis revealed that COX- 
2 was present only in rat macrophages previously stimulated with LPS (10 ^g/ml). 
This COX-2 expression was specifically inhibited when dexamethasone (2 mM) was 
introduced into the incubation medium. These results indicate that endogenous COX 
present in cells prior to LPS stimulation consists mainly of COX-1. Furthermore, 
enhanced activity of COX and the subsequent increase in prostaglandin secretion 
induced by LPS was due mainly to the selective expression of COX-2 and not due to 
increased COX-1 catalysis.
In the same study (Lee et al., 1992), a time course for COX-1 and -2 mRNA 
transcription was also determined following LPS stimulation. It was noted that the 
majority of mRNA contained in unstimulated rat macrophages was COX-1. However, 
when macrophages were stimulated with LPS, the majority of mRNA transcribed was 
that of COX-2. It was also noted that the kinetics of the COX-2 mRNA was fairly 
rapid, with maximal production occurring 6 hours following LPS stimulation. This 
high production of COX-2 mRNA was noted to continue for 24 hours, or the remainder 
of the time frame analyzed in this study. These data support those of Kujubu and 
Herschman (1992), who reported that dexamethasone directly inhibits TIS10 mRNA 
accumulation in transfected Swiss 3T3 cells.
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These results were further investigated to determine dexamethasone regulatory 
actions on interleukin-1-induced COX production in vitro (Feng et al., 1993). In this 
study, antibodies utilized for western blot analysis were produced in a manner similar 
to that reported by Lee et al. (1992), and their specificity determined using cos-7 cells 
previously transfected with recombinant rat DNA that transcribed both COX-1 and 
COX-2. Western blot analysis indicated that COX-2 is induced by interleukin-1 in 
vascular smooth muscle cells; whereas, COX-1 production is not affected. Also, 
dexamethasone was noted to inhibit the transcription of COX-2 mRNA and the 
translation of COX-2 itself. Dexamethasone had no effect on COX-1 translation.
Taken together, the studies reported herein and those of others (Raz et al., 
1989: Jacobs et al., 1994), indicate that COX metabolism and regulation is dependant 
upon the level of stress imposed on the animal system being evaluated. Stress, either 
natural or induced, appears to encourage the production of the COX-2 isozyme. This 
isozyme is rapidly induced upon stimulation, and is capable of increasing prostaglandin 
production anywhere from 10 to 80 fold (Simonson et al., 1991). It is these 
characteristics that have intrigued scientists in reproductive physiology. Since 
prostaglandins have been implicated in reproductive processes, such as ovulation and 
luteolysis, investigations into the role of COX-2 in these processes have been initiated.
Effect of Dexamethasone Administration on Reproductive Cyclic Events
The discovery of a novel, inducible isoform of the cyclooxygenase enzyme has 
increased the interest in reproductive processes of large and small animals that require the
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presence of prostaglandin. However, this isoform is stimulated in several biological tissues 
by a variety of compounds, including serum constituents (Mitchell and Trautman. 1993). 
lippopolysaccharide (Lee et al., 1992), hCG (Sirois and Richards, 1992; Sirois et al., 
1992; Sirois, 1994), platelet derived growth factor (O'Bannion et al., 1992) and 
forskolin and phorbol esters (Kujubu et al., 1991). Once stimulated, the COX-2 isoform 
is capable of producing prostaglandins at a rate that is 80 times greater than COX-1 
(Dewitt et al., 1993)
The majority of research involving COX catalysis in reproduction has focused on 
prostaglandin formation during the ovulatory process. It has been determined that the 
COX-2 isoform is responsible for the majority of prostaglandin production by rat (Sirois 
and Richards, 1992; Sirois et al., 1992) and bovine (Sirois, 1994) granulosa cells 
immediatley prior to ovulation. For each of these species, it was noted that COX-2 is 
stimulated by the preovulatory LH surge. Time course analyses performed in these studies 
have indicated that the production of COX-2 mRNA and protein are necessary for 
prostaglandin synthesis in preovulatory follicles. Differences in COX-2 kinetics may be 
responsible for the disimilar intervals from LH peak to ovulation observed among species.
Early studies have provided evidence that the luteolytic hormone, prostaglandin 
F2a, is responsible for luteolytic process in ruminants. Uterine prostaglandin secretion has 
been theorized to be involved in the luteolytic process of sheep (McCracken et al., 1972) 
and cattle (Hixon and Hansel, 1974). McCracken et al. (1971) demonstrated that 
prostaglandin F2a of uterine origin is transferred from the uterine vein to the ovarian
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artery, where it was then beleived to be responsible for corpus luteum regression. This 
model of luteal regression has been termed the counter current mechansism in the 
scientifiic literature. These data were supported by Hixon and Hansel (1974) who 
reported that sectioning the broad ligament ipsilateral to the corpus luteum resulted in an 
extension of the bovine estrous cycle. The fact that exogenous prostaglandin F2a 
administration to cows in the luteal phase of the estrous cycle causes luteal regression also 
supports the idea that prostaglandins are necessary for luteolysis in ruminants (see review 
by Hansel et al., 1973).
These findings lead one to consider that luteolysis in ruminants is a local 
mechanism involving the uterus and ipsilateral corpus luteum. However, additional 
observations have resulted in contradictory results. Milvae and Hansel (1980) reported 
that there is no significant increase in ovarian prostaglandin F2a concentration during 
periods when concentrations are high in the uterine vein. Questions also arise due to the 
fact that luteal cells themselves are capable of secreting prostaglandins during in vitro 
culture, indicating that luteal regression may not require prostaglandin F2a of uterine 
origin (Shemesh and Hansel, 1975; Milvae and Hansel, 1983). These findings suggest that 
arachidonic acid may be transferred from the uterus in a counter current exchange rather 
than prostaglandin F2a.
Various corticosteroids have been shown to adversely effect reproductive 
performance in farm animals. Cummings et al. (1980) reported that cattle injected 
daily with dexamethasone (30 mg) from the day of estrus (day 0) through day 2 of the
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estrous cycle had no effect on ovulation of estrous cycle length. This phenomenon has 
also been reported in cyclic mares (Ellsworth et al.. 1983). However, when 
dexamethasone (30 mg) was administered during the luteal phase of the estrous cycle 
(days 13 through 17), the length of the estrous cycle was extended in this study 
(Abdalla et al., 1980). Moreover, although estrous cycle length was extended, fertility 
of the subsequent estrous cycles were not impaired.
Liptrap and McNally (1976) reported the effects of hydrocortisone on the 
ovulatory mechanism of Holstein heifers. The experimental animals were administered 
hydrocortisone (1,000 mg/day from days 16 to day 4 of the subsequent estrous cycle) 
exhibited delayed ovulation (by 2 days) when compared with saline injected animals. 
Ovulation was completely inhibited when ACTH was administered during the same 
time period. This decrease in ovulation rate appeared to be caused by an abatement of 
LH secretion, since an oVulatory injection of hCG (10,000 IU) restored ovulation rates 
to those observed in control animals.
The adverse effects of stress on bovine reproduction have been directly linked 
to an inhibition of gonadotropin release from the pituitary. Physical restraint for 15 
minutes, twice daily during the follicular phase in cattle prevented the preovulatory 
surge in LH (Stoebel and Moberg, 1982b). No delay in the onset of estrus was 
observed when ewes were restrained following estradiol administration; however, 
when animals were primed with estradiol during restraint, the LH surge was delayed 
3 hours. Confinement induced stress has also been determined to decrease the
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amplitude and frequency of LH secretion in ewes (Rasmussen and Malven, 1983) and 
monkeys (Norman and Smith. 1992).
The administration of exogenous cortisol has also been shown to affect pituitary 
release of LH. The administration of cortisol to preovulatory staged Holstein heifers 
resulted in a prevention of the LH surge in three of four animals (Stoebel and Moberg, 
1982a). Similarly, the amplitude and frequency of LH secretion was decreased in 
postpartum suckled and nonsuckled beef cows (Dunlap et al., 1981).
Hydrocortisone and dexamethasone have also been demonstrated to affect the 
developing corpus luteum. Hereford heifers injected with ACTH (100 IU/day) on days 
2 through 8 of the estrous cycle had lower weight corpora lutea at slaughter (day 9) 
than did animals administered the vehicle control treatment (Wagner et al., 1972). In 
a susequent study, Wagner et al. (1977) demonstrated that ovarian perfusion of ACTH 
or hydrocortisone did not affect luteal function. However, carotid infusion on days 2 
to 9 of the estrous cycle resulted in a prolonged rise in progesterone production during 
the infusion period. No differences were noted in plasma progesterone concentrations 
on days 9 to 11 between the treated and control animals.
More recent studies have suggested that the lifespan of the bovine corpus luteum 
is extended following ACTH or dexamethasone administration. Pool et al. (1983) 
allotted crossbred beef cows to either free pasture or pen confinement and subdivided 
these groups into those receiving ACTH (200 IU/day) or vehicle on days 17 through 
21 of the estrous cycle. Animals confined to pens exhibited an extended estrous cycle
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length of approximately 2 days when compared with their pasture-housed counterparts. 
This extension of the estrous cycle was attributed to increased corpus luteum function 
as determined by plasma progesterone. When the data from pen and pasture housed 
animals were combined, the interval from progesterone decline to subsequent estrus was 
extended an average of 5.5 days. It appears that physical stress and induced stress (i.e., 
ACTH injections) have different physiological effects: physical stress causing increased 
corpus luteum lifespan and ACTH stress causing abnormal follicle development.
The same research group reported the effects of dexamethasone administration 
on reproductive performance in cattle (Ingraham et al., 1984). Animals were again 
assigned to pen or pasture confinement and dexamethasone was administered to cows 
allotted to each group on day 16 of the estrous cycle (20 mg/day) and days 17 through 
20 (30 mg/day). Interestingly, plasma progesterone and rectal palpation indicated that 
half (8 of 16) of the animals receiving dexamethasone had prolonged luteal function. 
Plasma progesterone profiles of individual animals indicated that the decline in 
progesterone concentration to below 1 ng/ml occured later in some dexamethasone 
treated animals when compared with the saline injected controls. Results from the 
endocrine profiles were substantiated by rectal palpation of functional corpora lutea.
Vighio and Liptrap (1990) observed some of the same trends of luteal extension 
following dexamethasone (2 mg) administration to cattle on days 13 through 17 of the 
bovine estrous cycle. Mean progesterone secretion above 1 ng/ml was extended an 
average of 10 days. It was also reported by the authors that dexamethasone lessened
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both estrogen and LH secretion. The estrogen surge was abated by dexamethasone, and 
the pulsatile release of LH was decreased in amplitude and frequency. These results 
suggest that dexamethasone may decrease estrogen secretion; thereby, decreasing 
estrogens biphasic effect on gonadotropin release from the pituitary. This decrease may 
be adequate to slow follicle development, but maintain corpus luteum function.
Cortisol has also been shown to act directly on bovine granulosa cells of small 
follicles (Kawate et al., 1993). Granulosa cells cultured in vitro in medium alone 
secreted significantly more estradiol than those cultured in medium containing cortisol 
(10 mM). Similarly, granulosa cells cultured in medium alone possessed a higher 
number of LH receptors on the cell membrane than did those cultured in medium 
containing cortisiol (. 1 or 10 mM). These data suggest that cortisol suppresses estradiol 
production by bovine granulosa cells by decreasing the number of LH receptors 
available for recognizing circulating LH.
A further study suggests that dexamethasone has direct effects on the brain 
(Pool, 1980). The administration of dexamethasone to cows on days 2 through 5 of the 
estrous cycle (20 mg) resulted in a lower number (25%) exhibiting standing estrus 
following exogenous estrogen administration. However, 100% of the control animals 
that were administered physiological saline exhibited standing estrus. This is in contrast 
to a standing estrus response noted in ovariectomized dairy heifers injected with 
estrogen (Melampy et al., 1957), which suggests dexamethasone can also act directly 
on the central nervous system by altering estrogen sensitivity.
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Summary
It is now apparent that prostaglandins play a vital role in many biological 
processes. The literature pertaining to prostaglandin function in reproductive processes 
has continued to expand in recent years with the discovery of the novel, inducible form 
of COX. However, the role of prostaglandins in reproductive processes requires a 
separation of their possible physiological actions from their pharmacological effects. 
Although pharmacological effects of prostaglandins are clinically significant, they may 
not reflect their true involvement in normal physiological processes.
It appears that stress, either natural or induced, has deleterious effects on 
reproduction. Its adverse effects on mammalian ovulation may be considered to be 
two-fold. Gonadotropin release is inhibited by chronic stress induction, resulting in 
abnormal or slowed follicle development. However, acute stress that occurs just prior 
to or during estrus may inhibit ovulation by suppressing prostaglandin formation in the 
preovulatory follicle. This mechanism of suppression may be related to cyclooxygenase 
acitivity, more specifically, COX-2 activity (Sirois, 1994).
One of the most notable observations as a result of dexamethasone 
administration is prolongation of the duration of the estrous cycle due to extended luteal 
function (Abdalla et al., 1980; Ingraham et al., 1984; Vighio and Liptrap, 1990).
It is not clear why only some animals exhibit extended luteal function following 
dexamethasone administration; however, it has been suggested that animals undergoing 
normal luteal regression, do so because the luteolytic mechanism was initiated prior to
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dexamethasone administration (Ingraham et al., 1984; Vighio and Liptrap, 1990). 
Dexamethasone may suppress luteolysis in those cows having extended luteal function 
by inhibiting cyclooxygenase activity in the uterus (Ingraham et al., 1984; Vighio and 
Liptrap, 1990), thereby disrupting the counter current exchange of prostaglandin F2a 
from the uterine vein to the ovary artery (Hixon and Hansel, 1974).
To date, the use of live animals for determining the effects of certain drugs 
remains the optimal method of obtaining true-to-fact biological conclusions. However, 
the use of current in vitro culture techniques may also be employed to gain further 
understanding of molecular events that occur during the microprocesses of 
reproduction. Tissue culture techniques allow researchers to isolate specific cell types 
and determine their function in processes such as ovulation. However, the medium 
used in these culture systems should be defined, and should not contain biological 
serum as a protein source. This is especially true, since serum alone has been shown 
to induce P450 side chain cleavage enzymatic activity in bovine granulosa cells (Skinner 
and Osteen, 1988) and bovine granulosa-luteal cells (Meidan et al., 1990). Similarly, 
serum constituents have been reported to induce prostaglandin formation by activation 
of the COX enzyme (Lee et al., 1992; Feng et al., 1993), thereby masking the effects 
of any added regulatory agents.
Therefore, it is of the utmost importance to produce a somatic cell culture 
system that would allow for cultivation of small numbers of granulosa cells, without 
stimulating catalysis of the enzyme being studied. This type of in vitro culture system
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would aid researchers working with small amounts of tissue by allowing for adequate 
numbers of cells to be produced for proper enzymatic studies to be performed. Also, 
a more defined culture system would preferably provide a more repeatable method of 
cultivation of different cell types, thereby allowing more consistent results to be 
obtained over time.
Based on the current knowledge from the scientific literature, a hypothesis was 
formulated. A hypothesis that involved the COX-2 isofom, which rapidly and 
transiently produces prostaglandins in large amounts, in reproductive processes. Such 
processes as ovulation and luteolysis are believed to require large amounts of 
prostaglandin for completion; Therefore, in vitro and in vivo studies were designed to 
determine the role and origin of prostaglandin formation during these reproductive 
processes.
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CHAPTER I 
EFFECT OF MEDIA SUBSTITUTES ON BOVINE MURAL GRANULOSA 
CELL FUNCTION AND PROLIFERATION DURING IN VITRO CULTURE 
Introduction
In vitro studies involving the culture of granulosa cells have expanded our 
knowledge of hormonally regulated follicular enzymes (Orly et al., 1980; Savion et al., 
1981b). To date, the most efficient method of increasing cell numbers in vitro involves 
use of serum-supplemented culture medium. However, the interpretation of results for 
hormonally-regulated enzymes is often unpredictable or complicated by the addition of 
serum to the culture medium (Orly et al., 1980; Erickson, 1983).
Serum contains an undefined composite of hormones, nutrients and growth and 
attachment factors necessary for cell maintenance and proliferation (Savion et al. 
1981a). Studies involving the effects of serum supplementation on granulosa cell 
function demonstrate that serum constituents alone are capable of inducing 
steroidogenesis, while masking the effects of added regulatory agents, such as forskolin 
and LH (Savion et al., 1981a; Skinner and Osteen, 1988; Meidan et al., 1990).
A recent attempt to propagate bovine granulosa cells using serum substitutes met 
with only limited success (Roberts and Echtemkamp, 1994). However, it has been 
determined that the addition of insulin (Channing et al., 1976; Veldhuis et al., 1985; 
Langhoutetal., 1991), epidermal growth factor, fibroblastic growth factor, and high-
41
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density lipids (Savion et al., 1981a) alone, or in combination can maintain cellular 
viability or support proliferation at a lower rate compared with serum-supplemented 
cultures.
Two experiments were designed to determine the effects of commercially- 
prepared serum replacers on in vitro proliferation and progesterone secretion by bovine 
granulosa cells during in vitro culture. The primary objective of this study was to 
evaluate the ability of serum-free culture systems to promote proliferation of granulosa 
cells without inducing steroidogenesis.
Materials and Methods 
Culture Medium and Supplements
The basal medium, Dulbecco's modified Eagle medium/Hams F-12 nutrient 
mixture (DMEM/F-12; 1:1 vol/vol), and GMS-X* (GMSX; media supplement 
containing 1.0 g/L insulin, .67 mg/L sodium selenite, .55 g/L transferrin and .2 g/L 
ethanolamine), fetal bovine serum (FBS), penicillin and streptomycin were purchased 
from Gibco Laboratories (Grand Island, NY). The SerXtend (SerXtend; containing 
FGF, EGF, insulin, BSA, transferrin (pasteurized human), ethanolamine, thioctic acid, 
selenium and hydrocortisone (<50 mg/ml protein) was provided by Irvine Scientific 
(Santa Ana, CA). The fatty acid-free BSA (FAF-BSA) was purchased from Sigma 
Chemical Co. (St. Louis, MO). A photograph of the medium substitutes used in this 
study as recieved by the manufacturer are represented in Figure 1.1.
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Figure 1.1. A photograph of the medium substitutes utilized in Experiment I, which 
include from left to right (back) SerXtend, FAF-BSA,GMS-X and (front) FBS.
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Granulosa Cell Isolation
For each experiment in Chapter I, ovaries from mixed breed beef cows were 
collected from a local abattoir in warm PBS containing 100 units penicillin and 100 
Mg/ml streptomycin (antibiotics) and transferred to the laboratory within 7 hours of 
collection. A single cell suspension of granulosa cells was obtained by aspirating 2- to 
8-mm follicles using a 20-gauge needle attached to a 10-ml syringe (Langhout et al., 
1991), and follicular aspirates were dispensed into 15-ml polypropylene conical 
centrifuge tubes (Figure 1.2). Approximately 10 to 15 ovaries were required to 
perform each replicate, with each ovary possessing 5 to 10 follicles. Tubes containing 
the granulosa cells were allowed to stettle at room temperature for 15 minutes to allow 
sedimentation of cumulus oocyte complexes and aggregated granulosa cells.
The supernatant was aspirated and the granulosa cells (primarily mural 
granulosa) were centrifuged at 200 x g for 10 minutes at 20 °C. Granulosa cells were 
then resuspended in 10 ml of basal medium (DMEM/F-12) containing 10% fetal bovine 
serum, and antibiotics (seeding medium). The cells were washed by centrifugation 
three times to remove follicular fluid and any residual contaminants. Following the 
final granulosa cell wash, the cells were resuspended in 10 ml of seeding medium, and 
the number of viable (non-stained) cells was determined manually by the use of a 
hemocytometer and the trypan blue exclusion method that was adapted from the 
previous work of Freshney (1987).
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Figure 1.2. A photograph of the tools utilized to isolate and culture bovine granulosa cells 
including the needle and syringe, bovine ovary, tissue culture flasks and conical tube.
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Experiment 1
The objective of Experiment 1 was to develop a defined culture system that 
would allow granulosa cell proliferation under serum-free conditions. The efficacies 
of two commercially-prepared medium additions to grow granulosa cells were 
compared with common medium supplements, FBS and FAF-BSA. For the initial 
seeding, 5 x 105 viable cells were placed into duplicate sets of 25-cm2 tissue culture 
flasks (5 flasks/treatment/replicate; Costar; Cambridge, MA) containing 5 ml of 
seeding medium. Cells were allowed to attach to the substratum for 48 hours in 
seeding medium and then washed once with basal medium. Culture flasks containing 
granulosa cells were randomly allotted to the following treatments: basal medium alone
(1), basal medium containing 1 % vol/vol FBS (2), 1 % vol/vol GMS-X (3), 4 mg/ml 
FAF-BSA (4), or 5 % vol/vol SerXtend (5). All cultures were maintained at 39 °C in 
an atmosphere of 95 % air and 5 % C 02.
On culture days 1, 2, 4, 6 and 8 of treatment culture, the number of granulosa 
cells/flask was determined and the culture medium was harvested. At each count, 
except days 1 and 8, media were aspirated and replaced with fresh treatment media in 
the remaining flasks.
Experiment 2
Based on the results of Experiment 1, two dose respnose trials were conducted 
to evaluate different concentrations of SerXtend and different seeding procedures on the
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rate of proliferation of granulosa cells. In the first trial, granulosa cells were initially 
seeded in 25-cm2 flasks with 5 x IQ5 cells in seeding medium for 48 hours. Following 
the seeding period, treatment media were allotted to duplicate sets of flasks (S 
flasks/treatment/replicate). The treatments consisted of basal medium alone (1), or basal 
medium containing 5% (2), 2.5% (3), 1.25% (4) or .625% SerXtend (5).
A second dose response trial was carried out to determine if reducing the initial 
seeding rate and period would allow adequate cell growth. Following the initial 
viability assessment and count, cells were seeded at 2.5 x 10s cells/25 cm2 flask and 
cultured in medium containing 10% serum for 24 hours prior to treatment culture. 
Treatment cultures consisted of basal medium (1), or basal medium containing 2.5 %
(2), 1.25 % (3), .625 % (4), .3125 % (5) or .078 % (6) SerXtend. Granulosa cell 
counts were determined on days 1, 2, 4, 6 and 8 of treatment culture for each trial and 
medium was replaced in the remaining flasks every other day of treatment culture, 
except on days 1 and 8.
Determination of Granulosa Cell Numbers and Medium Harvest
At designated intervals for each experiment, the number of granulosa cells in 
each flask was determined by removing the cells from the bottom of the culture vessel 
using a .05 % trypsin solution containing .2 mg/ml EDTA (Sigma). During the 
trypsinization procedure, flasks were incubated on an incubator/shaker at 39°C for 5 
to 10 minutes, or until the cells became rounded and lifted off the substratum. The cell
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suspension was then diluted with seeding medium (1:2 vol/vol) to inactivate the trypsin. 
The number of granulosa cells/treatment was determined using a hemacytometer and 
cell viability determined by the trypan blue dye exclusion method (Freshney, 1987). 
In Experiment 1 and 2, medium was harvested from flasks at each cell count, and 
centrifuged at 200 x g for 20 minutes at 20°C for later progesterone assay. 
Progesterone Concentration
Progesterone was analyzed in Experiments 1 and 2 using a previously validated 
RIA (Thompson et al., 1983). The RIA was performed in duplicate with appropriate 
standards. Standards were extracted with petroleum ether prior to RIA analysis. The 
progesterone antibody cross reacts with pregnenolone (.5%), estrone (<.01% ), 
testosterone (<  .01%) and androstenedione (.04%). Media samples were diluted 50- 
fold prior to the assay, with a 50-^1 volume of sample added to each tube. All values 
were obtained in a single assay, with an intra-assay coefficient of sl2.5 % with a 
percent recovery rate and binding rate of [3H] progesterone of 75% and 38%, 
respectively.
Statistical Analysis
For Experiment 1, granulosa cells from each of two groups of ovaries were 
randomly divided into two replicates for each treatment and sampling time, with a third 
batch of ovaries providing cells for a single replicate (n=5 replicates/treatment/time). 
For Experiment 2, two replicates were performed from each of two ovary batches (n=4
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replicates/treatment/time) for each response curve. Cell counts and progesterone 
concentrations were analyzed using least square analysis of variance and the PROC 
GLM procedure of SAS (1985). If the differences between treatments were significant, 
the PDIFF procedure of SAS was used to the compare means. Data were analyzed 
using the model components of ovary batch, treatment, ovary x treatment, 
replicate(ovary batch x treatment), time, ovary batch x time, treatment x time, ovary 
batch x treatment x time and residual. The effect of ovary batch and ovary batch x 
treatment was tested using replicate(ovary batch x treatment) as the error term. The 
effect of treatment was tested using ovary batch x treatment and the effect of time was 
tested using ovary batch x time. The effect of treatment x time was tested using ovary 
batch x treatment x time, and the remaining terms were tested with the residual.
Results
Experiment 1
Photomicrographs (40x) of bovine granulosa cells following 8-days of in vitro 
culture in medium supplemented with different substitutes are depicted in Figures 1.3 
through 1.5. Morphological characteristics of cells cultured in this study were similar 
to those reported by Savion et al. (1981a). In the present study, cells cultured in basal 
medium alone tended to become flattened and enlarged. Trypan blue exclusion staining 
performed on cells at each count also indicated low cell viability by day 6 of culture 
(data not shown). Those cells cultured in either FBS, FAF-BSA or SerXtend appeared
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Figure 1.3. A photomicrograph (40X) of bovine granulosa cells that were initially 
seeded (5 x 105 cells/flask) in medium containing 10% FBS for 48 hours. The 
photograph was made following 8 days of treatment culture in medium alone.
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Figure 1.4. A photomicrograph (40X) of bovine granulosa cells that were initially seeded 
(5 x 10s cells/flask) in medium containing 10% FBS for 48 hours. Pictures were taken 
following 8 days of treatment culture in medium containing 1% FBS (top) or 1 % GMSX 
(below).
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Figure 1.5. A photomicrograph (40X) of bovine granulosa cells following 8-days of 
serum-free culture in medium containing either 4 mg/ml FAF-BSA (top) or 5 % 
SerXtend (below).
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healthy, maintained an "epithelial-like" appearance and were >  85 % viable on day 8 
of culture. Cells cultured in these treatments formed small, tightly bound colonies from 
which they continued to proliferate until confluency. However, the cells cultured in 
GMSX appeared to take on a "fibroblast-like" appearance, exhibiting signs of 
elongation and a low nuclear to cytoplasmic ratio.
The initial seeding of bovine granulosa cells in medium supplemented with 10% 
FBS provided attachment and subsequent proliferation for all treatment media except 
the control. Cell populations during days 1 to 8 of culture in different treatment media 
are demonstrated in Figure 1.6. The basal mixture of DMEM/F-12 (Control) did not 
enhance cell proliferation. The addition of calf serum or FAF-BSA to the medium 
provided an increase (Pc.01) in cell numbers through day 4 when compared with 
granulosa cells cultured in the control medium, while a significant decline (P <  .05) in 
cell numbers followed confluency at day 4.
Treatment 3 (GMSX) also produced higher (P< .001) cell numbers compared 
with the control group through confluency (day 4 of treatment culture), followed by a 
rapid decline by day 6 and a slight, nonsignificant increase on day 8 of culture. The 
number of cells/flask was greater in Treatment 3 on day 2 and 4 of the culture period 
when compared with both the Treatment 2 (P <  .01) and Treatment 4 (P <  .01) and was 
greater (P< .001) than the control treatment on day 8. The SerXtend (Treatment 5)
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Figure 1.6. Proliferation (+SEM) by granulosa cells cultured in basal medium alone 
or medium containing FBS (1%), GMS-X (1%), FAF-BSA (4 mg/ml) or SerXtend 
(5%) following an initial seeding period of 48 hours and an initial seeding rate of 5 x 
105.
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produced the highest proliferation rate. Cell numbers in this group were greater 
(P <  .001) than all other treatments and there was no decline following confluency.
The steroidogenic capability of bovine granulosa cells in extended serum-free 
culture was evaluated by determining the amount of progesterone present in the media 
at 2-day intervals (Figure 1.7). Progesterone concentrations are reported on a 
normalized basis as ng of progesterone/100,000 viable cells. On days 1 and 2 of 
treatment culture, Treatments 1, 2, 3 and 4 produced greater (P< .001) concentrations 
of progesterone when compared with those of Treatment 5. On day 4 of treatment 
culture, granulosa cells in Treatment 4 produced more (Pc.05) progesterone than 
Treatment 1, 3 and 5 but was not different from Treatment 2.
The bovine granulosa cells in Treatments 1 and 5 produced the least amount of 
progesterone. The ranking trend in progesterone production was similar for days 6 and 
8, with Treatments 2, 3 and 4 producing more (P < .001) progesterone than Treatments 
1 and 5. Overall, progesterone production by cells in all treatments was elevated 
beginning on day 4 of culture; however, progesterone secretion by granulosa cells 
cultured in Treatments 2, 3 and 4 remained significantly higher (P<.01) than 
Treatments 1 and 5 throughout the remaining culture period.
Experiment 2
Experimental conditions for Experiment 2 also provided for cell proliferation 
for each SerXtend medium concentration evaluated (Figure 1.8). There were no
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Figure 1.7. Progesterone production (±SEM) by granulosa cells cultured in different 
treatment media in Experiment 1. Progesterone concentrations were normalized on a 
number of viable cells/ng of progesterone (10'3) basis. Bars within days with different 
letters differ as indicated in the Results text section.
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Figure 1.8. Proliferation (±SEM) by granulosa cells cultured in basal medium or basal 
medium containing 5%, 2.5%, 1.25% or .625% SerXtend following an initial seeding 
period of 48 hours and an initial seeding rate of 5 x 10s.
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difference in cell proliferation rates between SerXtend treatments at each evaluation 
time. Bovine granulosa cell proliferation was greater (PC.Ql) in the SerXtend 
treatments (2 through 5) when compared with the controls on days 1, 2, 4 and 6, but 
proliferation of these groups was not significantly different from the control group on 
day 8 of culture. For each treatment, cell confluency was reached at approximately day 
4 of treatment culture, after which cell numbers declined. Cell numbers remained 
consistently low in the control treatment during the 8-day evaluation period, indicating 
that the culture medium alone was not capable of stimulating the granulosa cells into 
mitotic division.
On days 1 and 2 of culture, the cells in the control group produced a higher 
(P< .05) concentration of progesterone when compared with the SerXtend treatments 
(Figure 1.9). However, on day 6 of culture, progesterone secretion was significantly 
higher (PC.01) in the SerXtend Treatments 3, 4 and 5 (2.5 %, 1.25% and .625 % 
SerXtend, respecitvely). Also, progesterone production by SerXtend-treated cells 
gradually increased during the culture period, and was significantly greater for each 
SerXtend treatment when compared with the control treatment (medium alone) on day 
8 of treatment culture.
Figure 1.10 represents the proliferation of cells that were seeded at a rate of 2.5 
x 105 cells/25-cm2 flask and cultured in medium containing 10% serum during the 
initial 24 hour seeding period. As expected, cells cultured in the control medium alone
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concentrations of SerXtend in Experiment 2. Progesterone concentrations were 
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Figure 1.10. Proliferation (±SEM) by granulosa cells cultured in basal medium, or 
basal medium containing 2.5%, 1.25%, .625%, .3125% or .078% SerXtend following 
an initial seeding period of 24 hours and an initial seeding rate of 2.5 x 105.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
61
did not increase in number. However, when cultured in medium containing .3125% 
or greater SerXtend, granulosa cell populations gradually increased beginning on day 
4 and continuing through day 8 of treatment culture. Treatments 2 and 3 produced a 
significantly higher (P< .001) number of cells when compared with Treatments 4, 5 
and 6 on day 6 of treatment culture. On day 8 of treatment culture, Treatment 2 
produced a higher (P < .001) number of cells than Treatment 5 but was not greater than 
Treatments 3 and 4. Proliferation rates of granulosa cells cultured in Treatment 6 
medium did not differ from the control group (medium alone).
Discussion
These experiments demonstrate that granulosa cells can be cultivated in a serum- 
free culture system. The basal medium was able to maintain the majority of cells that 
had attached during the initial serum seeding period for up to 8 days in culture, as was 
previously reported for granulosa cells cultured in Hams F-12 medium (Skinner and 
Osteen, 1988). In contrast, both the FBS and FAF-BSA induced granulosa cell 
proliferation at approximately the same rate. These data are in agreement with those 
of Borano and Hammond (1985) who noted similar proliferations rates of bovine 
granulosa cells between FBS and FAF-BSA.
Removal of serum from granulosa cell cultures (control) resulted in a significant 
decline in progesterone production over the culture interval (Figures 1.7 and 1.9). In 
comparison, progesterone production by cells cultured in FBS- or FAF-BSA-
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supplemented media increased from days 4 to 6 of culture and was maintained at day 
8. Progesterone concentrations for the FBS- and FAF-BSA-supplemented treatments 
were significantly greater than in control culture at these sampling periods. Therefore, 
serum and its albumin constituent, may mask the effects of luteotropic agents added to 
the medium in nonproliferative cells (control) during the 6 to 8 day culture period 
following serum removal. However, the high proliferative capacity of granulosa cells 
grown in medium containing SerXtend appears to override the ability of the cells to 
produce progesterone immediately following serum removal. Therefore, if  granulosa 
cells are grown to confluency using medium containing the SerXtend, regulatory agents 
may be added following a relatively short equilibration period in a maintenance 
medium.
Differences in cell proliferation rates may offer a possible explanation for the 
high progesterone production observed in the control group versus the low production 
by SerXtend treated cells. Progesterone production by cells incubated in the SerXtend 
treatment (Figure 1.7) was inversely related to cell numbers (Figure 1.6). When 
mitogenic activity was high (days 1 through 4), progesterone production was low, and 
when proliferation rates were low (days 6 and 8), progesterone production was 
increased. This inverse relationship between proliferation and steroidogenesis has been 
reported for bovine granulosa cells (Orly et al., 1980; Erickson, 1983; Meidan et al., 
1990). These data, along with other results from our laboratory, indicate that granulosa
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cells cultured in extended serum-free environments for up to 8 days are capable of 
secreting progesterone upon subsequent stimulation.
The stimulation of progesterone production by nonproliferating cells in the 
SerXtend treatment, during the latter stages of culture, may be a function of the insulin 
contained in the SerXtend preparation. Mitogenic and steroidogenic effects of insulin 
have been reported for bovine (Savion et al., 1981a; Langhout et al., 1991; Spicer et 
al., 1993), porcine (Borano and Hammond, 1985; May et al., 1988) and primate 
(Woodruff et al., 1993) granulosa cells in serum-free culture systems. Langhout et al. 
(1991) reported an increase in cell proliferation and steroidogenesis by bovine granulosa 
cells collected from both small and large follicles. The mitogenic effects of insulin 
have been associated with its affinity for the IGFl receptors, as opposed to direct action 
through its own receptor (May and Schomberg, 1981; Savion et al., 1981a).
In our study, the medium supplement (GMS-X, consisting of insulin, selenium, 
transferrin and ethanolamine) adequately supported granulosa cell proliferation but 
produced levels of progesterone similar to that of FBS. This phenomenon has been 
reported by other investigators (Veldhuis et al., 1985; Langhout et al., 1991; Spicer et 
al., 1993), and may be considered a problem in studies involving hormonal regulation 
of follicular enzymes. Progesterone secretion stimulated by serum-supplemented 
culture media may mask some effects of added regulatory agents, such as forskolin or 
cAMP, when studying the regulation of the P450scc enzyme (Skinner and Osteen,
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1988; Meidan et al., 1990). Similarly, serum constituents have been reported to induce 
prostaglandin formation by activation of the COX enzyme (Mitchell and Trautman, 
1993).
The SerXtend used in this study is classified as a serum substitute containing 
less than 50 mg/ml of protein. According to the manufacturers recommendations, 12.5 
ml of SerXtend should be added to 500 ml of serum, which in turn reduces the amount 
of serum needed in the culture medium. However, in the present study, SerXtend alone 
was added to the media without the addition of serum. SerXtend is reported to contain 
FGF, EGF, insulin, BSA, transferrin, ethanolamine, thioctic acid, selenium and 
hydrocortisone. This substitute was studied because of the observation by Savion et 
al. (1981a) that EGF and FGF alone did not produce a mitogenic effect in vitro, but 
when combined with insulin, these growth factors increased cell proliferation over that 
of insulin alone. In our study, the SerXtend milieu also produced a mitogenic effect 
greater than the insulin treatment (GMS-X).
When cells were seeded at an initial rate of 5 x 10s, cell confluency was reached 
between days 2 and 4 of the culture interval for the SerXtend treatment. In contrast, 
when granulosa cells were seeded at a lower rate (2.5 x 10s), they tended to proliferate 
in a moderate rate during the first 4 days of treatment culture, and were slower to reach 
confluency; however, their cell number increased by the 6th and 8th day of culture. 
In a previous report, granulosa cells originally seeded in FBS and then cultured on a
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
plastic substratum in serum-free medium containing FGF and high density lipids did not 
proliferate (Savion et al., 1981a). However, in this study, insulin-containing medium 
was able to induce proliferation when cells were seeded at low concentrations. 
Apparently, cell-to-cell contact is the limiting factor in the proliferation of granulosa 
cells in serum-free media when no collagen matrix is utilized.
Currently, the most effective methods to culture bovine granulosa cells require 
the addition of serum to the culture medium, which often produces variable responses. 
A commercially-prepared serum substitute (SerXtend) was able to stimulate bovine 
granulosa cell proliferation in culture for up to 8 days without significant loss of 
cellular integrity as determined by the trypan blue dye exclusion method. Moreover, 
when performing hormonal regulation studies, it may be beneficial to use SerXtend to 
avoid triggering steroid synthesis during the proliferative stages of culture. This ability 
to grow granulosa cells from small follicles may, in the future, enhance our 
understanding of granulosa cell growth and differentiation. The use of this serum 
substitute may allow for the determination of the causative factors involved in granulosa 
cell proliferation and steroidogenesis and their specific mechanisms during 
folliculogenesis.
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CHAPTER n
CORTICOSTERONE REGULATES PROSTAGLANDIN FORMATION BY 
FORSKOLIN STIMULATED BOVINE MURAL GRANULOSA CELLS 
FOLLOWING EXTENDED SERUM-FREE CULTURE
Introduction
The most efficient methods of increasing cell numbers in vitro involves the use 
of serum-supplemented culture medium. However, the interpretation of results from 
experiments dealing with hormonally-regulated enzymes is complicated by the addition 
of serum to the culture medium (Orly et al., 1980; Erickson, 1983). This is due to an 
undefined mixture of hormones, nutrients and growth and attachment factors that 
serum contains (Savion et al., 1981).
Studies involving the effects of serum supplementation on granulosa cell 
function demonstrate that serum constituents alone are capable of inducing 
steroidogenesis, while masking the effects of exogenous regulatory agents, such as 
forskolin and LH (Savion et al., 1981; Skinner and Osteen, 1988; Meidan et al., 1990). 
However, Broussard et al. (1995) noted that a commercially-prepared serum substitute 
was able to promote bovine granulosa cell proliferation, while minimizing steroido­
genesis. The mitogenic potential of this serum substitute enabled the production of 
large number of cells through in vitro culture, allowing low numbers of granulosa cells 
to be increased prior to the addition of regulatory agents, such as forskolin or 
corticosterone.
68
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Espey (1980) proposed a general model for mammalian ovulation, which 
included the accumulation of prostaglandins in the liquor folliculi near the time of 
ovulation. The exact mechanism of prostaglandin-induced ovulation is not known; 
however, the ecosinoids are thought to have a variety of local functions in the 
preovulatory follicle, including fibroblast proliferation, chemotaxis, vasodilation and 
destruction of connective tissue (for review see Espey, 1980, 1994). Several reports 
implicate COX-2 (the inducible isoform of the cyclooxygenase enzyme) in the rapid 
formation of the cyclooxygenase prostaglandins in the rat preovulatory follicle (Sirois 
and Richards, 1992; Sirois et al., 1992) following stimulation by hCG near the time of 
ovulation. More recently, the COX-2 isozyme was found to be present in the granulosa 
cells of hCG stimulated preovulatory follicles of the cow (Sirois, 1994).
Therefore, a preliminary and two primary experiments were designed to 
determine if bovine granulosa cells cultured in a serum-free in vitro environment were 
able to respond to the regulatory agent, forskolin, an adenylate cyclase activator that 
has been reported to mirror in vivo LH activity (Meidan et al., 1992), by producing 
progesterone and prostaglandins. The primary objective of the study was to establish 
if the COX isozyme is responsible for prostaglandin formation by forskolin stimulated, 
in vitro cultured granulosa cells. Corticosterone, which specifically inhibits COX-2 
prostaglandin formation (Lee et al., 1992), was added to the culture medium to 
distinguish between the function of COX-1 and COX-2 in this prostaglandin formation.
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Materials and Methods
Culture Medium and Supplements
The basal medium, Dulbecco's modified Eagle medium/Hams F-12 nutrient 
mixture (DMEM/F-12; 1:1 v/v), and GMS-X* (GMS-X; a medium supplement 
containing 1 g/L insulin, .67 mg/L sodium selenite, .55 g/L transferrin and .2 g/L 
ethanolamine), fetal bovine serum (FBS), penicillin and streptomycin were purchased 
from Gibco Laboratories (Grand Island, NY). Arachidonic acid and hydrocorti­
costerone were purchased from Sigma Chemical (St. Louis, MO). The SerXtend* 
(SerXtend; a serum substitute reported by the manufacturers to contain fibroblast 
growth factor (FGF; bovine), epidermal growth factor (EGF; murine), insulin, BSA, 
transferrin (pasteurized human), ethanolamine, thioctic acid, selenium and hydro­
cortisone (<50 mg/ml protein) was supplied by Irvine Scientific (Santa Ana, CA). 
Granulosa Cell Isolation
Ovaries from mixed breed beef cows of unknown origin were collected from a 
local abattoir in warm PBS containing antibiotics and transferred to the laboratory 
within 5 hours. A single cell suspension of granulosa cells was obtained by aspirating 
2- to 8-mm diameter follicles, as previously described by Broussard et al. (1995). 
Briefly, the follicular aspirates were dispensed into 15-ml polypropylene conical 
centrifuge tubes that were incubated at room temperature for 15 minutes to allow for 
sedimentation of cumulus oocyte complexes and aggregated granulosa cells. The
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follicular fluid was aspirated and the cells washed three times with 10 ml of DMEM/F- 
12 containing 10% FBS, 100 units penicillin and 100 ^g/ml of streptomycin (seeding 
medium) by centrifugation at 200 x g for 10 minutes at 20°C. The cells were then 
resuspended in 10 ml of seeding medium, and the number of viable cells determined 
(Freshney, 1987).
Culture Phases
For each experiment described herein, the granulosa cell culture was split into 
three separate phases including a seeding, a proliferative, and an experimental phase 
(see Figure 2.1). The seeding and proliferative phases were utilized to produce large 
cell numbers for the experimental phase and were performed as previoulsy described 
(Broussard et al., 1995) in a similar manner for all experiments. For the initial seeding 
phase, 2.5 x 10s viable cells were pipetted into duplicate sets of 25-cm2 tissue culture 
flasks (Costar; Cambridge, MA) containing 5 ml of seeding medium. Cells were 
allowed to attach to the substratum for 24 hours in seeding medium and then washed 
once with 2 ml of basal medium. Once seeded, the granulosa cells were washed once 
with 2 ml of basal medium, and then 5 ml of basal medium containing SerXtend (1 % 
v/v) was dispensed into the duplicate sets of flasks. This proliferative phase consisted 
of a 6 day granulosa cell culture in SerXtend to allow for granulosa cell proliferation 
to confluence, followed by a wash with 2 ml of basal medium and a 1-day equilibration 
period with basal medium containing 1% v/v GMSX (GMSX medium; five ml/flask).
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Figure 2.1. A schematic drawing of the experimental design for Experiment 1. The abbreviations "FBS" represents fetal 
bovine serum, "GMSX" represents GMSX medium, "Foisk" represents forskolin, "h" represents hour and "AA represents 
arachidonic acid.
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Medium was changed every other day during the proliferation phase, and all cultures 
were maintained at 39°C in an atmosphere of 95% air and 5 % C02.
Preliminary Experiment
The objective of the Preliminary Experiment was to determine if bovine 
granulosa cells respond to the regulatory agent, forskolin, following 6 days of serum- 
ffee culture by secreting progesterone into the medium. Flasks (n =  72, 6 treatments 
x 4 sampling periods x 3 replicates) containing a confluent monolayer of granulosa cells 
were randomly allotted to one of six treatment media consisting of 5 ml of basal 
medium alone (Treatment 1, negative control) or basal medium containing forskolin 
(Treatment 2), 1% FBS (Treatment 3; positive control), 1% FBS plus forskolin 
(Treatment 4), GMSX medium (Treatment 5) and GMSX medium plus forskolin 
(Treatment 6). All treatment media that contained forskolin (Treatments 2, 4 and 6) 
did so at a 10 uM concentration. The treatment culture persisted for 6 days, with 
medium changes and sampling times occurring on days 1, 2, 4 and 6 of treatment 
culture.
Experiment 1
The specific objective of Experiment 1 was to determine if in vitro cultured 
bovine granulosa cells were capable of producing prostaglandin F2« in response to 
forskolin stimulation at the time previously determined to occur in in vivo preovulatory 
follicles (Sirois, 1994). A duplicate set of 25 cm2 flasks (n = 36; 3 treatments x 4
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sampling periods x 3 replicates) were grown to confluency as described in the Culture 
Phase section. The experimental phase began immediately following the 1-day 
equilibration period, and was designated as Time 0 (hour) for the experimental phase 
(see Figure 2.1).
Granulosa cells cultured in the control treatment (Treatment 1; see Figure 2 .1A) 
remained in GMSX medium for the remainder of the culture period (24 hours). 
Granulosa cells cultured in Treatment 2 medium (see Figure 2. IB) were incubated in 
GMSX medium 16 hours (beginning from Time 0), at which time the flasks were 
washed once with 2 ml of basal medium and replaced with 5-ml of GMSX medium 
plus arachidonic acid (10 mM) was added. For Treatment 3 (see Figure 2.1C), 
granulosa cells were exposed to a 5 hour incubation period (beginning at Time 0) with 
GMSX medium plus forskolin (10 ^M). Flasks were then washed once with 2 ml of 
basal medium and the granulosa cells were then cultured for 11 hours in GMSX 
medium. At hour 16, flasks in Treatment 3 were again washed once with 2 ml basal 
medium that was replaced with GMSX medium plus arachidonic acid (10 ^M). For 
Treatments 1 and 2, GMSX medium was removed from the flasks 5 hours following 
the initiation of the experimental phase and replaced with 5 ml of fresh GMSX medium 
to remain consistent with medium changes in Treatment 3.
The medium was harvested at 2-hour intervals during the sampling period (18, 
20, 22 and 24 hours post-initiatior! of the experimental phase) and frozen at -80° C until
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later assay for prostaglandin F2a . During the experimental phase, all flasks contained 
5 ml of treatment medium, which was removed from each treatment flask at each 
sampling period and replaced with fresh culture medium appropriate to that treatment. 
Culture medium was not replaced in treatment flasks on days 1 and 8 of treatment 
culture.
Experiment 2
The objective of Experiment 2 was to determine if corticosterone, which 
selectively inhibits prostaglandin formation by the COX-2 isozyme was capable of 
inhibiting prostaglandin secretion by forskolin-stimulated granulosa cells. The 
experimental phase (n =  36 flasks; 4 treatments x 3 sample periods x 3 replicates) for 
Treatment 1 (control) and Treatment 2 in Experiment 2 were identical to Treatments 
1 and 3 in Experiment 1, respectively. The experimental phase for Treatments 3 and 
4 in Experiment 2 was identical to Treatment 3 in Experiment 1, except corticosterone 
(1 and 10 mM, respectively) was added 16 hours into the experimental phase, along 
with arachidonic acid.
Media were harvested at 2-hour intervals during the sampling period (18, 20 and 
22 hours of the experimental phase) and frozen at -80°C until assayed for prostaglandin 
F2a . During the experimental phase, all flasks contained 5 ml of treatment medium, 
which was removed from each treatment flask at each sampling period and replaced 
with fresh medium appropriate to that treatment.
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Progesterone and Prostaglandin F2a Determination
Progesterone values for the Preliminary Experiment were analyzed using a 
radioummunoassay previously validated by Thompson et al. (1983). The RIA was 
performed in duplicate with appropriate standards. Standards were extracted with 
petroleum ether prior to RIA analysis. The progesterone antibody used cross reacts 
with pregnenolone (.5%), estrone (<  .01%), testosterone (<.01%) and 
androstenedione (.04%). Each medium sample was diluted 50-fold prior to the assay, 
with a 50-^1 volume of sample added to each tube. The percent recovery and binding 
of [3H] progesterone was 75% and 38%, respectively.
Prostaglandin F2a values were obtained using an enzyme immunoassay kit 
originating from Cayman Chemical (Ann Arbor, MI). The assay was performed in 
accordance with the protocols that accompanied the kits. According to the 
manufacturer the prostaglandin F2a antibody has a cross reactivity of 100 % with 
prostaglandin F2a, F,a and F3a; 7% with 6-keto prostaglandin Fta; <.5% with 
prostaglandin A3 ; .3% with 2,3-dinor-6-keto prostaglandin F,a and <.1% with 
prostaglandin Ej, 6 ,15-dideto-13,14-dihydro prostaglandin Fia, thromboxane Bj and 
prostaglandin Ej. Media samples were added to the 96-well plates precoated with 
murine monoclonal antibody at a volume of 50 (A, and the plates read at 412 nm. 
Values for both progesterone and prostaglandin F2o were obtained in a single assay, 
with an intra-assay coefficient of sl3 %.
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Statistical Analysis
For the Preliminary Experiment and Experiments 1 and 2, granulosa cells from 
one group of ovaries were randomly divided into three replicates for each treatment and 
sampling time (n=3 replicates/treatment/time period). Progesterone and prostaglandin 
F2cc concentrations in the medium were analyzed using least square analysis of variance 
and the PROC GLM procedure of SAS (1985). If the differences between treatments 
were significant, the PDIFF procedure of SAS was used for mean comparisons. Data 
were analyzed using the model components of treatment, replicate (treatment), time, 
treatment x time and residual. The effect of treatment was tested using treatment x time 
and the effect of time was tested using replicate (treatment), and the remaining terms 
were tested with the residual.
Results
Preliminary Experiment
Results from the Preliminary Experiment indicate that bovine granulosa cells 
were capable of responding to forskolin by secreting progesterone in vitro (Figure 2.2). 
Granulosa cells cultured in the control and control plus forskolin treatments did not 
differ in mean progesterone production on days 1, 2 and 4 of incubation. Mean 
progesterone production was significantly increased (P< .01) from cells cultured in FBS 
plus forskolin when compared with cells cultured in FBS alone at all sample periods 
evaluated. A similar significant increase was noted for cells cultured in GMSX medium
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Figure 2.2. Mean progesterone production (+SEM) by bovine granulosa cells 
following a seven day serum-free culture period. Letters within each treatment day 
represent a significant difference of at least P <  .001.
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when compared with GMSX medium plus forskolin treatment on days 2 and 4 of 
culture. However, progesterone production was not different between the two GMSX 
medium treatments on days 1 and 6 of culture. Progesterone production was not 
different among the control treatment (Treatment 1) and the FBS and GMSX treatments 
(Treatments 3 and 5) at all sampling periods.
Experiment 1
Granulosa cells cultured in the control medium secreted the least amount of 
prostaglandin F2a into the culture medium (Figure 2.3). The addition of arachidonic 
acid to the medium during the experimental phase (Treatment 2) resulted in a 
numerically higher (P > .05) secretion of prostaglandin F2a than cells cultured in the 
control medium. However, those cells treated with forskolin and arachidonic acid 
(Treatment 3) secreted much larger amounts (P< .0001) of prostaglandin F2a into the 
medium than the control or the arachidonic acid treated cells at the 18, 20, 22 hour 
sampling periods. Cells in Treatment 3 also secreted significantly more (PC .05) 
prostaglandin F2a at the 24 hour sampling period when compared with control and 
Treatment 2 concentrations.
Experiment 2
Granulosa cells in the control (Treatment 1) and forskolin plus arachidonic acid 
(Treatment 2) treatments secreted concentrations of prostaglandin F2a into the medium 
at a rate similar to their respective secretions in Experiment 1 (Figure 2.4). Granulosa
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cells in Treatment 2 secreted significantly more (P <  .0001) prostaglandin F2a than the 
control group at each sampling period evaluated. The addition of 1 mM of 
corticosterone to the culture medium decreased prostaglandin F2a secretion at 18 
(P <  .001) and 20 (P <  .05) hours after the cells were exposed to forskolin treatment. 
There was no difference (P=.06) in prostaglandin F2o secretion between Treatments 
2 and 3 at the 22 hour sampling period. However, when 10 of corticosterone 
(Treatment 4) was added to the medium, prostaglandin F2a secretion by the granulosa 
cells was significantly decreased (P<.0001) to levels similar to the control group 
(Treatment 1) at all time periods.
Discussion
It would be of great benefit to be able to cultivate bovine granulosa cells in a 
serum-free environment. This is especially true since FBS alone has been noted to 
stimulate hormonally regulated enzymes, such as the P450 side chain cleavage enzyme 
in the production of progesterone (Savion et al., 1981; Skinner and Osteen, 1988) and 
the COX enzyme in the production of prostaglandins (Lee et al., 1992; Mitchell and 
Trautman, 1993). In a Preliminary Experiment, forskolin significantly increased 
progesterone production by granulosa cells that had previously been cultivated in a 
serum-free environment. Progesterone secretion by granulosa cells was significantly 
greater when stimulated by forskolin in the FBS- and GMSX-based medium when 
compared with nonstimulated counterparts (Treatments 3 and 5, respectively) on days 
2 and 4 of treatment culture. These data indicate that cultivation in a serum-free
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environment does not adversely affect the ability of bovine granulosa cells to respond 
to a potent regulatory agent, forskolin.
Forskolin was utilized in the current study because of it has been reported to 
mimic gonadotropin activity in bovine granulosa cells (Meidan et al., 1990; 1992). 
Results of Experiment 1 results indicated that forskolin-stimulated prostaglandin F2a 
secretion from granulosa cells cultivated in a manner similar those in the Preliminary 
Experiment was increased when compared with the control treatment. The 
prostaglandin F2a precursor (arachidonic acid) , added to ensure it's availability to the 
cells, did not stimulate prostaglandin F2a secretion above control levels, and was 
significantly less than the forskolin stimulated cells.
These results are in agreement with in vivo studies performed in the rat (Sirois 
and Richards, 1992; Sirois et al., 1992) and indicate that compounds having luteinizing 
hormone-like activity stimulate prostaglandin F2a formation in bovine granulosa cells. 
More specifically, bovine granulosa cells harvested from small follicles and grown in 
a serum-free, in vitro environment were able to produce prostaglandin F2a at time 
periods similar to those noted to occur in in vivo preovulatory follicles (Sirois, 1994). 
These previous findings, along with the results from the current study, lend credence 
to the hypothesis that prostaglandin F2a plays a significant role in the process of 
mammalian ovulation during the critical time period just preceeding the release of the 
oocyte into the reproductive tract (see reviews by Espey, 1980; Murdoch et al., 1993).
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Results from Experiment 2 indirectly implicate COX-2 as being the isoform that 
is responsible for the majority of prostaglandin F2e secretion by in vivo cultured, 
forskolin-stimulated, bovine granulosa cells. Prior to the characterization of COX-2, 
studies indicated that gluccocorticoids and/or dexamethasone suppress prostaglandin 
formation in endotoxin stimulated human mononuclear cells (Seibert et al., 1990) and 
interleukin 1 stimulated human dermal cells (Raz et al., 1989). More specifically, Lee 
et al. (1992) determined that dexamethasone specifically inhibits COX-2 mRNA 
production of prostaglandin in endotoxin-stimulated macrophages of the mouse, without 
affecting COX-1 mRNA production. Therefore, the results of the current study suggest 
that prostaglandin secretion by bovine granulosa cells is a function of COX-2 enzymatic 
acitivity.
It is apparent that serum-free culture is a viable alternative to FBS supplemented 
culture, at least in-so-far as the enzymes that regulate progesterone and prostaglandin 
F2a are concerned. Also, the 7-day serum-free culture apparently allows for granulosa 
cell maturation. Richards and Bogovich (1982) previously reported that granulosa cells 
harvested from small antral follicles of the rat are incapable of producing prostaglandins 
following LH stimulation. The ability to grow steroidogenically functional bovine 
granulosa cells from small antral follicles may enhance our understanding of granulosa 
cell growth and differentiation during the process of folliculogenesis. It also appears 
that translation of COX-2 is the rate limiting process in determining the interval from
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the preovulatory surge in LH to ovulation, which is conserved across species. In the 
future, a similar culture system may provide answers to other regulatory mechanisms 
in different cell types.
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CHAPTER HI
THE PRESENCE OF A NOVEL CYCLOOXYGENASE ISOFORM IN THE 
MURAL FOLLICULAR GRANULOSA CELLS OF FSH 
STIMULATED WOMEN
Introduction
Cyclooxygenase is a rate limiting enzyme that catalyzes the conversion of 
arachidonic acid to various prostaglandins (Sigal, 1991). The original COX isoform 
has an approximate MW of 69,000 and 70,000 in the mouse (Hedin et al., 1987) and 
bovine species (Sirois, 1994), respectively. Both proteins are translated from a 2.8 kb 
mRNA transcript. There are reports in the literature describing the presence of a novel 
COX (COX-2) isoform produced by in vitro cultured tracheal mucosal cells (Rosen et 
al., 1989). This isoform has a MW of 72,000 and is translated from a 4.0 kb mRNA 
(Rosen et al., 1989). A similar COX isoform has also been isolated in the bovine 
(Sirois et al., 1994) and humans (Hla et al., 1994).
Cyclooxygenase has been shown to play an important role in prostaglandin 
formation during mammalian ovulation, which has been compared to an inflammatory 
response (Espey, 1980). The accumulation of prostaglandins in the follicular fluid in 
humans is inhibited by the administration of the NSAID indomethacin (Killick and 
Elstein, 1987), and has since been reported to inhibit production of both the COX-1 and 
-2 iso forms (Meade et al., 1993). This inactivation of the cyclooxygenase enzyme 
occurs by an irreversible acetylation of the Ser-530 position (DeWitt et al., 1990).
88
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
The cDNA encoding this protein, has been cloned in human vascular endothelial 
cells using polymerase chain reaction primers from the murine TSI10 sequence (Jones 
et al., 1993). Human COX-2 is translated from a 4.3 kb mRNA and has an 
approximate MW of 72,000 (Jones et al., 1993). Hla and Neilson (1992) reported the 
stimulation of prostaglandin secretion by cos-7 cells previously transfected with human 
COX-2 cDNA. This increase was appreciably reduced following a 2 hour incubation 
in medium containing dexamethasone.
Recent reports have demonstrated the presence of COX-2 in the granulosa cells 
of preovulatory follicles of the rat (Sirois and Richards, 1992; Sirois et al., 1992). 
Production of the COX-2 isoform was noted to occur 2 to 5 hours following the 
administration of an ovulatory dose of hCG (Sirois and Richards, 1992). Also, the 
mural granulosa cells of preovulatory follicles have been stimulated to transcribe COX- 
2 mRNA and translate COX-2 protein following hCG administration in prostaglandin 
F2a short-cycled cows (Sirois, 1994).
The current study was undertaken to determine if the COX-2 isoform is present 
in human preovulatory follicles. This would be the first report implicating this novel 
isoform in human ovulation. Granulosa cells were harvested from the ovaries of FSH 
stimulated females by the use of transvaginal ultrasound guided aspiration, and the 
COX cellular content determined by western blot analysis using a polyclonal antibody 
that recognizes both the COX-1 and -2 isoforms.
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Materials and Methods
Materials
For the Stimulation protocol, the Pergonal* and Metrodin* used in this study 
were purchased from Serono Laboratories, Randolf, MA, the leuprolide acetate 
(Lupron*) from TAP Pharmaceuticals Inc., Deerfield, IL and the Pregnyl (hCG) was 
purchased from Organon Inc., West Orange, NJ. The oocyte flushing medium, Human 
Tubal Fluid Medium (HTF-HEPES) was purchased from Irvine Scientific, Inc., Santa 
Ana, CA and the medium supplement Plasmanate* purchased from Miles, Inc., Elkhart, 
ID.
FSH Stimulation
Female patients (n= 16) ranging from 29 to 41 years of age (average age ±SEM 
=  35+.9) with nonendocrine reproductive deficiences were utilized in the study. The 
reproductive anomalies persisting in these patients, or their spouses included ovarian 
adhesions, tubal blockage and unexplained male factor. Patients were advised to notify 
the clinic as to the initial day of menses (day 1 of the menstrual cycle), and plasma 
estradiol concentrations were determined and an ultrasound examination performed to 
ensure that there was no ovarian cystic condition.
Subjects were GnRH downregulated with a GnRH agonist (Lupron; 5 mg/ml) 
prior to follicle stimulation. Females were administered daily injections of . 1 ml of 
Lupron, begining on day 15 of the menstrual cycle, for 15 days followed by 9 days of
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.5 ml injections of Lupron. Subjects were administered (i.m.) an average of 3 ampules 
of Metrodin (75 IU FSH t>er amtmle) and 2 amoules of Personal (75 IU FSH and 75
v A. A '  A  W  \
IU LH per ampule) per day for 9 days, beggining on the 20th day of Lupron therapy. 
On day 9 of FSH stimulation, patients were administered a 10,000 IU i.m. injection of 
hCG to initiate in vivo oocyte maturation.
Granulosa Cell Collection and Isolation
Ultrasonic examinations and follicle aspirations were conducted using an 
Ultrasound System 4 (Advanced Technology Laboratories, Tempe, AZ) ultrasound 
attached to a 7.5 MHz probe. Follicles with a diameter greater than 1 mm were 
aspirated from individual patients under general anesthesia using a 16 guage needle 
(O'Neil Aspiration and Irrigation Needle, Go Medical Industries Ltd, Subiaco, Western 
Australia) to obtain oocytes for in vitro fertilization (IVF).
Follicles were lavaged 2 to 3 times with 1 ml of warm flushing medium (HTM- 
HEPEA containing 10 % plasmanate) to increase the recovery rates of both the follicle 
enclosed oocyte and the mural granulosa cells, and collected into a 15 ml conical 
centrifuge tube (Becton Dickinson, Lincoln Park, NJ). The aspirate was then poured 
into a 60-mm petri dish (Falcon; Becton Dickinson) and searched under a light 
microscope for oocytes at 37°C in 5% C 02 using a portable IVF Chamber (TVF 
Isolette, Hoffman Surgical Equipment Company, Conshocken, PA).
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Immediately following isolation of the human oocytes, the remaiming granulosa 
cells were aspirated from the 60-mm oetri dish using a pastuer pippette, pooled for each 
individual patient, and then dispensed into 2 ml epindorf centrifuge tubes (Brinkmann 
Instrument Company, Westbury, NY). Granulosa cells were washed once by 
centrifugation at 800 x g for 7 minutes. The supernatant was removed from the 
centrifuge tubes and discarded, and the granulosa cell pellet stored at -80°C for later 
assay for COX content.
Western Blot Analysis
Protein extraction was performed as previously reported by Sirois and Richards 
(1992). Granulosa cells were homogenized in a TED buffer (20 mM Tris, pH 8, 10 
mM EDTA and . 1 mM DEDTC) containing 2 mM octyl glucoside and centrifuged at 
30,000 x  g for 1 hour at 4 °C. The crude pellets were then sonicated (8 sec/cycle, 3 
cycles) in TED buffer containing 45 mM octyl glucoside and the sonicates centrifuged 
at 100,000 x g for 60 minutes at 4 °C. The supernatant was harvested and stored at 
-80°C until electrophoretic analysis. Protein concentration was determined by the 
method of Bradford (1976).
Proteins (50 iug) present in solubilized cell extracts were resolved by one­
dimensional sodium dodecyl sulfate-poly acrilamide gel electrophoresis (SDS-PAGE). 
Proteins were electrophoretically transferred to nitrocellulose filters as previously 
described (Sirois and Richards, 1992). Filters were incubated with antibody (9181) that
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recognizes both COX-1 and -2 isoforms previously diluted 1:10 in 10 mM Tris buffered 
saline (pH =  7.5) containing 2 % nonfat dry milk. Polyclonal antibodies raised in 
rabbits against purified ovine COX were affinity purified on a cyanogen bromide- 
acitivated sepharose column using ovine COX as the ligand (Sirois and Richards, 
1992). [125I] protein A (1 x 106 cpm/ml in tris buffered saline containing 2 % milk) 
was used to visualize proteins. Filters were washed in Tris buffered saline containing 
5% Tween and exposed to film at -80 °C (Kodak XAR-5, XRP, Eastman Kodak). For 
quantitative purposes, protein blots for individual patients were separately and 
arbitrarily rated by two individual technichians on a scale from 1 to 4 (1 =  little to no 
precipitation; 4 = high precipitation).
Plasma Estradiol Concentration
Plasma estradiol concentrations were obtained from the individual patient 
samples collected prior to ultrasound-guided transvaginal aspiration. Estradiol 
concentrations were analyzed on a total estradiol and a follicle diameter basis for this 
study. The four sequential plasma samples harvested and the corresponding ovarian- 
follicular sonagrams taken from each individual patient immediately prior to ultrasound- 
guided transvaginal aspriation were used in the analysis. Estradiol concentrations were 
determined using a fully automated enzyme immunoassay procedure (Immulite*; Los 
Angeles, CA) that had a reported working range of 20 to 2,000 pg/ml level of 
detection.
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Statistical Analysis
Granulosa cells from 16 patients were harvested and frozen as a single unit. 
Serum estradiol concentrations and follicle diameters were analyzed using least square 
analysis of variance and the PROC GLM procedure of SAS (1985). If the differences 
in estradiol concentration or follicle diameter among COX scores were significant, the 
PDIFF procedure of SAS was used to the compare means. Data were analyzed using 
model components of COX score, patient within COX score, day, COX score x day. 
The main effect of COX score was tested using patient within COX score mean square 
as the error term and the effect of day was tested using COX score x day mean square.
Results
To determine whether COX isoforms were present in preovulatory follicles, 
protein extracts were prepared from granulosa cells isolated approximately 36 hours 
following administration of an ovulatory dose of hCG. Proteins were analyzed by 
immuno-blotting using a polyclonal antibody having specificities previously described 
in rats (Sirois and Richards, 1992) and sheep (antibody No. 9181 recognizes both COX- 
1 and COX-2 isoforms) (Wimsatt et al., 1993).
The immunoreactive protein appeared as a 52,000 mw band (Figure 3.1), 
believed to correspond to a breakdown proteolytic fragment of COX-2 as explained by 
Sirois and Richards (1992) in rat granulosa cells, Hla and Neilson (1992) in human
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umbilical vein endothelial cells and in bovine granulosa cells (Sirois et al., 1994). In 
contrast, the antibody (No. 9181) did not recognize COX-1 in human granulosa cells.
Two of the 16 patient granulosa cell samples were recorded as having a minimal 
COX score of 1 (Figure 3.1; lanes 1 and 8, from left to right). Two of the patient's 
granulosa cells had a score of 2 (lanes 2 and 14), while four of the patient's granulosa 
cells were awarded a score of 3 (lanes 3, 7, 11 and 15). There were eight granulosa 
cell samples that were awarded a score of 4 (lanes 4, 5, 6, 9, 10, 12, 13, and 16).
Total estradiol concentrations, separated by COX score are represented in Figure 
3.2. Gel bands classified as having a COX score of 1,2 or 3 had similar total plasma 
estradiol concentration on days 5, 4, 3 and 2 before aspiration. The gel bands assigned 
a COX score of 4 had significantly higher of plasma estradiol 4, 3 and 2 days before 
transvaginal oocyte aspiration.
Average follicle diameter separated by COX score is represented in Figure 3.3. 
Those gel bands having a COX score of 4 had significantly larger average follicle 
diameter when compared with gel bands scoring 2 and 3, 5 days before aspiration. 
There was no difference in follicle diameter among the different COX scores 4 days 
prior to transvaginal aspiration. However, average follicle diameter was significantly 
larger 3 days before transvaginal oocyte aspiration for gel bands rated as 4. There was 
no difference in mean follicle diameter among the COX scores 2 days before 
transvaginal aspiration.
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Figure 3.1. Western blot analysis for the presence of COX-2. Each lane of 
the radiogram represents granulosa cells harvested from a single patient. 
Solubilized extracts were prepared follicle granulosa cells as described in the 
Materials and Methods section. Proteins (50 ^g/Iane) were analyzed by one­
dimensional SDS-page and immunoblotting, using anti-COX antibody No. 
9181 (see Sirois, 1994). Human blood platelets were run as a standard. 
Markers on the left and right of patient lanes indicate the migration of 
molecular weight standards.
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Figure 3.2. Comparison of total mean plasma estradiol concentration (±SEM) 
separated by COX score for the 4 plasma samples harvested from individual patients 
beggining 2 days before ultrasound-guided transvaginal oocyte aspration. The letter "a" 
within days represents a significant difference.
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difference.
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Discussion
Collectively, these results provide convincing evidence that the increased 
prostaglandin secretion by mammalian follicles before ovulation (Espey, 1980) is 
associated with the selective induction of COX-2 in granulosa cells. This study is the 
first to establish that the granulosa cells of human preovulatory follicles are capable of 
producing COX-2 following the administration of gonadotropins at ovulatory levels, 
suggesting that the obligatory mechanism regulating the synthesis of prostaglandins is 
conserved across the rat (Sirois and Richards, 1992), bovine (Sirois, 1994) and human 
species. It is also important to note that antibody raised in rabbits against ovine COX 
is capable of recognizing human COX-2 antigen.
Although the molecular weight of the COX-2 isoform differs from conventional 
reports (Rosen et al., 1989; Xie et al., 1991), this phenomenon has been previously 
reported. In cattle, Sirois (1994) described the presence of a second, lower mw band 
of approximately 59,000 isolated from the granulosa cells of hCG stimulated bovine 
preovulatory follicles. Similarly, Hla and Neilson (1992) noted the presence of a lower 
mw protein (52,000) isolated from cos-7 cells transfected with cDNA of human COX- 
2. Hla and Neilson (1992) suggested that the lower molecular weight protein may have 
been translated from an incomplete mRNA fragment constructed during its 
amplification via the polymerase chain reaction (PCR) methodology. However, both 
laboratories also suggested that this lower mw protein is a breakdown product of the
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intact COX-2 protein. Since PCR technology was not employed during the study by 
Sirois (1994) or in the present study, it is assumed this protein is indeed a breakdown 
product of the intact COX-2 molecule.
Human chorionic gonadotropin has been reported to induce prostaglandin 
formation in granulosa cells of the cow (Sirois, 1994), rat (Hedin et al., 1987; Sirois 
and Richards, 1992) and human (Lumsden et al., 1986) preovulatory follicle. 
However, one important difference in the regulation of rat vs human preovulatory 
follicles is the distinct time course of COX-2 induction. Rat COX-2 mRNA and 
protein are curtailed 9 hours after hCG treatment, while the induction of COX-2 protein 
in human mural granulosa cells occurs later, being detected approximately 36 hours 
following hCG administration. Although this difference appears suprising at first, it 
should be expected that granulosa cells of rats and humans at comparable stages of 
development (preovulatory) would produce prostaglandins at different times following 
hCG administration due to the differing times of ovulation between the two species.
In the rat, the interval from time of hCG administration to ovulation is 
approximately 14 to 16 hours (Sirois et al., 1992) compared with 38 to 42 hours 
reported in humans (Lumsden et al., 1986). These observations may reveal one 
mechanism regulating the normal duration of the ovulation process. Although it was 
not possible to measure prostaglandin concentration in the human preovulatory follicles 
aspirated in the present study, Lumsden et al. (1986) determined that prostaglandin F2a
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secretion by granulosa cells increases 36 hours following hCG administration. Also, 
oocyte maturation appears to coincide with follicle maturation and prostaglandin F2« 
production, since preovulatory follicle prostaglandin F2a production increases at the 
same time the oocyte extrudes the first polar body in vivo (Seibel et al., 1984).
In summary, the identification of COX-2 as a novel, distinct isoform that is 
present in the granulosa cells of hCG stimulated follicles offers new insight into the 
regulatory mechanisms involved in human ovulation. This mechanism appears to have 
been conserved across species, since similar COX-2 stimulation has been reported in 
the rat (Sirois and Richards, 1992; Sirois et al., 1992) and bovine (Sirois, 1994) 
species. This mechanism may be the regulatory process by which the length of the 
ovulatory process is determined across species. These results may lead to in vitro 
regulatory studies using serum-free culture methods (Broussard et al., 1995) to cultivate 
human granulosa cells. The understanding of COX-2 production and regulation by 
NSAIDS may improve our comprehension of the ovulatory process and their potential 
role as a birth control method in humans (Killick and Elstein, 1987).
References
Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram 
quantities of protein utilizing the principle of protein dye binding. Anal. Chem. 
72:248-254.
Broussard, J. R., J. K. Thibodeaux, M. W. Myers, J. D. Roussel, and W. Hansel and 
R. A. Godke. 1995. Effect of media substitutes on bovine granulosa cell 
function and proliferation during in vitro culture. J. Anim. Sci. 50:333-339.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
102
DeWitt, D. L., E. A. El-Harith, S. A. Kraemer, M. J. Andrews, E. F. Yao, R. L. 
Armstrong, and W. L. Smith. 1990. The aspirin and heme-binding sites of 
ovine and murine prostaglandin endoperoxide synthases. J. Biol. Chem. 
265:5192-5198.
Espey, L. L. 1980. Ovulation as an inflammatory reaction-A Hypothesis. Biol. Reprod. 
22:73-106.
Hedin, L., D. Gaddy-Kurten, R. Kurten, D. L. DeWitt, Smith.WL, and J. S. 
Richards. 1987. Prostaglandin endoperoxide synthase in rat ovarian follicles: 
Content, cellular distribution, and evidence for hormonal induction preceding 
ovulation. Endocrinol. 121:722-731.
Hla, T ., and K. Neilson. 1992. Human Cyclooxygenase-2 cDNA. Proc. Natl. Acad. 
Sci. 89:7384-7388.
Jones, D. A., D. P. Carlton, T. M. McIntyre, G. A. Zimmerman, and S. M. Prescott. 
1993. Molecular cloning of human prostaglandin endoperoxide synthase type II 
and demonstration of expression in response to cytokines. J. Biol. Chem. 
268:9049-9054.
Killick, S., and M. Elstein. 1987. Pharmocological production of luteinized unruptured 
follicles by prostaglandin synthetas inhibitors. Fertil. Steril. 47:773-777.
Lumsden, M. A., R. W. Kelly, A. A. Templeton, P. F. A. Van Look, I. A. Swanston, 
and D. T. Baird. 1986. Changes in the concentration of prostaglandins in 
preovulatory human follicles after administration of hCG. J. Reprod. Fertil. 
77:119-124.
Meade, E. A., W. L. Smith, and D. L. DeWitt. 1993. Differential inhibition of
prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and 
other non-steroidal anti-inflammatory drugs. J. Biol. Chem. 266:6610-6614.
Rosen, G. D., T. M. Birkenmeier, A. Raz, and M. J. Holtzman. 1989. Identification 
of a cyclooxygenase-related gene and its potential role in prostaglandin 
formation. Bioch. Biophys. Res. Comm. 164:1358-1365.
SAS. 1985. SAS user's guide: Statistics. SAS institute Inc., Cary, NC.
Seibel, M. M., S. L. Swartz, D. Smith, L. Levesque, and M. L. Taymor. 1984. In 
vivo prostaglandin concentration in human preovulatory follicles. Fertil. Steril. 
42:482-485.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
103
Sigal, E. 1991. The molecular biology of mammalian arachidonic acid metabolism. 
Am. J. Physiol. 260:L13-L28.
Sirois, J. 1994. Induction of prostaglandin endoperoxide synthase-2 by human chorionic 
gonadotropin in bovine preovulatory follicles in vivo. Endocrinol. 135:841-848.
Sirois, J., and J. S. Richards. 1992. Purification and characterization of a novel, 
distinct isoffom of prostaglandin endoperoxide synthase induced by human 
chorionic gonadotropin in granulosa cells of rat preovulatory follicles J. Biol. 
Chem. 267:6382-6388.
Sirois, J., D. L. Simmons, and J. S. Richards. 1992. Hormonal regulation of 
messenger ribonucleic acid encoding a novel isoform of prostaglandin 
endoperoxide H synthase in rat preovulatory follicles. J. Biol. Chem. 
267:11586-11592.
Wimsatt, J., P. W. N. Nathanielsz, and J. Sirois. 1993. Induction of prostaglandin 
endoperoxide synthase isoform-2 in ovine coytedonary tissues during late 
gestation. Endocrinol. 133:1068-1076.
Xie, W., J. G. Chipman, D. L. Roberson, and D. L. Simmons. 1991. Expression of 
a mitogen-responsive gene encoding prostaglandin synthase regulated by mRNA 
splicing. Proc. Natl. Acad. Sci. 88:2692-2696.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
CHAPTER IV
EFFECTS OF DEXAMETHASONE ADMINISTRATION TO DIESTRUS
COWS ON SYSTEMIC PROGESTERONE, ESTRADIOL AND 
UTERINE CYCLOOXYGENASE PRODUCTION
Introduction
Prostaglandin H synthetase, also referred to as COX, is the initial rate limiting 
enzyme in the prostaglandin, lipoxin and leukotreine synthesis pathways (Mitchell and 
Trautman, 1993). Recent studies involving the regulatory mechanisms of prostaglandin 
production have demonstrated the presence of two isoforms of the COX enzyme (Rosen 
et al., 1989). Cyclooxygenase-1 (COX-1; mw ~ 70,000), the original isozyme isolated 
from sheep vesicular glands (Miyamoto et al., 1976), is translated from a 2.8 kb 
mRNA . Correspondingly, the COX-2 isozyme is translated from a 4.0 kb mRNA and 
has a molecular weight of 72,000 (Kujubu et al., 1991; Xie et al., 1991).
Prior to the characterization of the COX-2 enzyme, dexamethasone reportedly 
inhibited prostaglandin formation in endotoxin stimulated mice, but did not affect its 
basal production (Masferrer et al., 1990). Similarly, cattle administered dexamethasone 
intramuscularly exhibited an extended luteal phase that has been reported to be a 
function of either decreased estrogen and preovulatory LH production (Vighio and 
Liptrap, 1990) or by an inhibition of the production of enzymes that are necessary to 
complete the COX pathway of eicosanoid production (Pool et al., 1983; Ingraham et 
al., 1984). However, more recent studies indicate that dexamethasone selectively
104
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inhibits the inducible form of the COX-2 isozyme in mitogen stimulated macrophages 
of mice (Masferrer et al., 1992) and rats (Lee et al., 1992).
The objectives of the current experiment were 1) to determine if  the COX-2 
isozyme is produced by the uterine endometrium during the luteolytic phase of the 
bovine estrous cycle, and 2) to determine if dexamethasone extends the lifespan of the 
corpus luteum by inhibiting the production of the COX-2 isozyme by the uterine 
endometrium during the mid-luteal phase of the estrous cycle.
Materials and Methods
Treatment Allocation
Crossbred beef cows with a body condition score of 6 or greater (0 to 9) were 
selected from the experimental physiology herd and maintained on native pasture at the 
St. Gabriel Agricultural Research Station, St. Gabriel, Louisiana. Cows that exhibited 
two previous estrous cycles ranging between 18.5 and 24 days were allotted to this 
study. At the initiation of the experiment, cows were randomly assigned to treatments, 
separated and maintained in .8-ha pastures, with pasture rotation performed as 
necessary and minerals fed free choice.
Cows in the control group (n=4) were administered an intramuscular injection 
of the treatment vehicle twice daily (0800 and 2000 h) on days 13 - 22 (estrus = day 
0) of the treatment estrous cycle. Cows in the dexamethasone group (n=5) were
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similarly administered 8 mg of synthetic dexamethasone (Azium*) twice daily on days 
13 through 22 of the treatment estrous cycle.
Blood Sampling
Blood samples were collected via venipuncture daily beginning on day 13 and 
continuing through day 22 of the treatment cycle. Immediately prior to the morning 
treatment injection, blood samples were harvested from the tail vein in vaccutainer 
tubes containing heparin with a 20 gauge vaccutainer needle (Vacutainer®, Becton 
Dickinson Co., Rutherford, NJ) and placed on ice. The whole blood was then 
centrifuged at 400 x g for 15 minutes, the plasma aspirated, and stored at -80°C until 
assayed for progesterone and estradiol.
Hormone Analysis
Progesterone values were obtained using a previously validated 
radioummunoassay method (Thompson et al., 1983). Estradiol concentrations were 
determined using commercial estradiol kits (Systems Diagnostic, Webster, TX). All 
values for each steroid were obtained in a single assay, with an intra-assay coefficient 
of variation of  ^12.5 %.
Endometrial Sampling
Uterine endometrial biopsies were performed on cows assigned to both 
treatment groups on days 16, 19 and 22 of the treatment estrous cycle. On the 
designated days following the morning treatment injection, individual cows were
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prepared for uterine biopsy by epidural injection of 5 ml of a 1% lidocaine solution 
(W. A. Butler Company. Columbus. OH). The external genitalia were cleansed with 
a betadine solution. A sterile biopsy instrument (Figure 4.1) was introduced through 
the os cervix and endometrial samples were retrieved in the posterior portion of each 
uterine horn on alternating collections days. Immediately following retrieval, endo­
metrial tissue was freed from connective tissue, carefully blotted on soft tissue to 
remove excess blood, dissected into 10 mg segments and frozen at -80°C until 
subsequent protein assay and western blot analysis.
Western Blot Analysis
Protein extraction was performed as previously reported by Sirois and Richards, 
1992. Uterine endometrial samples were homogenized using a TED buffer (20 mM 
Tris, pH 8, 10 mM EDTA and . 1 mM DEDTC) containing 2 mM octyl glucoside and 
centrifuged at 30,000 x g for 1 hour at 4°C. The crude pellets were then sonicated (8 
sec/cycle, 3 cycles) in TED buffer containing 45 mM octyl glucoside and the sonicates 
centrifuged at 100,000 x g for 60 minutes at 4°C. The supernatant was harvested and 
stored at -80°C until electrophoretic analysis. Protein concentration was determined 
by the method of Bradford (1976).
Western blot analysis using anti-COX antibody No. 9181, was performed as 
previously described by Sirois (1994). Briefly, 50 Mg of total protein present in 
solubilized cell extracts were resolved by one dimensional SDS-PAGE. Proteins were
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Figure 4.1. A photograph of the uterine biopsy instrument utilized to harvest uterine 
endometrial samples on days 16, 19 and 22 of the treatment cycle.
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then electrophoretically transferred to nitrocellulose filters. Filters were incubated with 
antibody (No. 9181) that recognizes both COX isoforms in the cow. Filters were 
washed in Tris-buffered saline containing 5 % Tween and exposed to film at -80°C 
(Kodak XAR-5, XRP, Eastman Kodak). Radiograms were then mounted on cardboard 
backing and visually analyzed for the presence or absence of either COX.
Statistical Analysis
Progesterone and estradiol data were analyzed using a split-plot design with 
repeated measures (Gill and Hafs, 1970). The model components included treatment, 
cow(treatment), day, treatment by day and residual. Means were separated using the 
PDIFF option of SAS. Days to progesterone decline to <  lng/ml, days from 
progesterone decline to estrus and mean treatment cycle length were analyzed using a 
one-way ANOVA.
Results
Mean estradiol concentrations for cows in the control and dexamethasone 
treatments are represented in Figure 4.2. A peak in systemic estradiol was noted in the 
control group on day 15 of the treatment cycle, which was significantly greater 
(P < .01) than the dexamethasone treated cows. A significant rise (P <  .01) in estradiol 
was also noted in the control cows on days 20 to 22 of the treatment cycle when 
compared with the levels in the dexamethasone-treated cows. Mean estradiol
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Figure 4.2. Mean estradiol concentrations (+SEM) for cows in the dexamethasone and 
control treatments during the experimental estrous cycle. Animals in the 
dexamethasone group received 8 mg dexamethasone twice daily between days 13 
through 22, while animals in the control group were treated with the vehicle alone. 
The letter "a" indicates a significant difference between the two treatments (P<  .01).
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concentrations in the dexamethasone-treated animals remained suppressed during the 
treatment cycle, never again rising above 3 pg/ml.
Mean progesterone concentrations obtained during the treatment cycle for both 
treatment groups are represented in Figure 4.3. Mean progesterone concentrations were 
not different between the control and dexamethasone-treated cows on days 10 to 17 of 
the treatment cycle. Circulating progesterone concentrations in the dexamethasone 
treated group were significantly lower (P <  .01) than the control cows on days 18 to 20 
of the cycle. Circulating progesterone levels by the control cows declined on days 21 
and 22 of the cycle and were not different from those circulating levels in the 
dexamethasone treated cows.
There was no difference in the interval from estrus to progesterone decline to 
<  1 ng/ml between the two treatment groups (Table 4.1). Mean intervals from the 
onset of estrus to the time when progesterone declined to < lng/ml in the treatment 
cycle for control and dexamethasone-treated animals were 21.3 and 19.4 days, 
respectively (P< .01). However, the mean interval from progesterone decline to below 
1 ng/ml during the diestrus phase of the treatment cycle to the post-treatment cycle 
estrus was significantly greater (P< .01) for the dexamethasone-treated animals when 
compared with control cows administered vehicle (11.6 and 2.6 days, respectively). 
This notable increase in the interval from progesterone decline below 1 ng/ml to estrus.
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Figure 4.3. Mean progesterone (+SEM) production by dexamethasone and control 
treated cows during the experimental estrous cycle. Animals in the dexamethasone 
group received 8 mg dexamethasone twice daily between days 13 through 22, while 
animals in the control group were treated with the vehicle alone. The letter "a" 
indicates a significant difference between the two treatments (P<  .01).
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Table 4.1. Effect of diestrous dexamethasone injections on the interval from estrus to 
progesterone decline to < lng/ml, the interval from progesterone decline to <  1 ng/ml 
to estrus, and mean treatment cycle length.___________________________________™------------------ - -
P4 decline P4 decline Mean treatment
Treatment <  1 ng/ml (day) to estrus (days) cycle length (days)
Control 21.3±.3 2.6±.8a 24 ±3.5*
Dexamethasone 19.4±.9 11.6±1.6b 31±2b
aP4 = progesterone.
b,cMeans within columns with different superscripts differ (P< .01).
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largely contributed to an extension (P<  .01) in the overall mean treatment cycle length 
in the dexamethasone-treated cows compared with the control group (31 versus 24 days, 
respectively).
The western blot analysis indicated that the COX-2 isozyme was not present at 
any time period evaluated in the uterine endometrial tissue sampled from cows in either 
treatment group. Detectable levels of the COX-1 isozyme were noted in endometrial 
tissue samples collected from both treatment groups at various stages of collection 
(Figure 4.4). However, no discemable pattern was noted between the detection of 
COX-1 and subsequent time of luteolysis in individual cows in either treatment.
Discussion
Parenteral administration of dexamethasone to diestrus cattle resulted in a 
significant increase in estrous cycle length, as was previously reported (Pool et al., 
1983; Ingraham et al., 1984). Importantly, circulating progesterone profiles over the 
treatment cycle indicate that this lengthening of the estrous cycle was not due to an 
extension of corpus luteum function. Rather, the absence of an increase in circulating 
levels of estradiol in dexamethasone treated animals tends to indicate that follicle 
development was at least, in part, abated. This concept was further supported by the 
fact that dexamethasone treated animals required an extended 12-day period to reinitiate 
estrous cycle activity following luteolysis (progesterone < 1 ng/ml).
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Figure 4.4. Western blot analysis for the presence of the COX-1 Isozyme. 
Numbers within treatment brackets indicate individual cows. Solubilized 
extracts were prepared from uterine endometrium as described in the Materials 
and Methods section. Proteins (40 /ug/lane) were analyzed by one-dimensional 
SDS-pageand immunoblotting, using anti-COX antibody No. 9181 (see Sirois, 
1994). Purified ovine prostaglandin G/H synthase (oPGS-1; 25 ng) was run as 
a standard. Markers on the left indicate the migration of molecular weight 
standards.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
116
Previous reports suggest that the administration of dexamethasone to diestrus 
cattle affects the steroidogenic capabilities of both the growing follicle and the 
regressing corpus luteum. In vivo, excessive systemic dexamethasone and/or ACTH 
decreases gonadotropin secretion from the anterior pituitary (Johnson et al., 1982; Li 
and Wagner, 1983). Vighio and Liptrap (1990) noted that both the frequency and 
amplitude of LH pulses decrease with dexamethasone administration, thereby inhibiting 
follicle development and estradiol production. However, basal production of LH was 
not affected by dexamethasone production (Stoebel and Moberg, 1982; Vighio and 
Liptrap, 1990).
Ingraham et al. (1984) found that dexamethasone injections to mid-luteal phase 
heifers resulted in an extended corpus luteum lifespan over saline-treated heifers. It 
was hypothesized by the authors that dexamethasone acts at the level of the uterus, 
disallowing formation of the luteolytic substance prostaglandin F2a. These results, in 
conjunction with those described (Johnson et al., 1982; Li and Wagner, 1983), suggest 
that the ability of dexamethasone to extend the lifespan of the corpus luteum may be 
two-fold. The first may be suppression of gonadotropin pulses mediated by the hypo­
thalamus and, in turn follicle development (Johnson et al., 1982), which is necessary 
for luteolysis to occur (Thatcher et al., 1986). It was suggested that pulsatile secretion 
of gonadotropins would be adversely affected; however, basal LH secretion would not 
be influenced, thus allowing for maintenance of the corpus luteum.
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A second method by which dexamethasone might increase the lifespan of the 
corpus luteum is by inhibiting production of uterine Prostaglandin F2c, as previously 
proposed in this laboratory (Ingraham et al., 1984). In the current study, it was 
hypothesized that luteolysis is associated with the induction of uterine COX-2 
production, and that dexamethasone treatment would decrease production of the COX-2 
isozyme and the subsequent increase in prostaglandin F2a production that is usually 
associated with luteal regression. This proved not to be the case.
Different physiological mechanisms have been proposed to regulate the expression 
of the COX isozymes. The COX-1 isozyme is constitutively produced and believed to 
be involved in the homeostatic regulation of prostaglandin formation for normal gastric 
and vascular function (Dewitt et al., 1993). The COX-2 isozyme has been associated 
with "immediate response" situations, in which prostaglandins must be produced at a 
rapid rate in instances such as inflammation, ovulation (Dewitt et al., 1993), and 
possibly luteolysis. Since dexamethasone has been shown to specifically suppress 
production of the COX-2 isozyme in mitogen stimulated rats (Lee et al., 1992), it was 
hypothesized that uterine endometrial COX-2 production by cows receiving 
dexamethasone would be suppressed, while maintaining some level of COX-1 
production. Conversely, in the absence of dexamethasone, the uterine endometrium of 
the control cows was expected to produce some level of COX-2 during the luteolytic 
phase of the bovine estrous cycle.
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The COX-1 isoform was produced sporadically throughout the sampling periods 
by the uterine endometrium of cows in both the control and dexamethasone treatments. 
In contrast, the COX-2 isozyme was not detected in either the control or dexameth­
asone-treated cows. Sirois (1994) has reported the induction of the COX-2 isozyme in 
the preovulatory follicles of cows treated with human chorionic gonadotropin. 
However, in the preovulatory follicle, the kinetics of the COX-2 isozyme appear to be 
quite rapid, with only a short window of production between 18 to 26 hours following 
the human chorionic gonadotropin injection. In the present study, it is possible that the 
sampling periods may have been too infrequent to detect production of COX-2 in the 
uterine endometrium or that uterine COX-2 production is not involved in prostaglandin 
formation during luteolysis.
In summary, our study suggests that the extension of the bovine estrous cycle by 
daily injections of dexamethasone (days 13 through 22) is not dependant on an 
extension of corpus luteum function, but rather on delayed or impaired preovulatory 
follicle development, as evidenced from decreased circulating estradiol levels. Also, 
this study does not support the working hypothesis that induction of COX-2 is involved 
during luteolysis. However, we cannot exclude the possibility that the COX-2 isozyme 
may be transiently expressed in the uterus at the time of luteolysis and that its lack of 
detection in the present study could have resulted from infrequent sampling periods. 
Currently, our laboratory is examining the possibility that the COX-2 isozyme converts
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arachidonic acid to prostaglandin in the corpus luteum itself, rather than in the bovine 
uterine endometrium.
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CONCLUSIONS
For years there has been disputes on the mechanisms involved in mammalian 
ovulation and luteolysis. The experiments conducted document the effectiveness of a 
serum-free culture system as a tool to cultivate large numbers of bovine granulosa cells. 
This is especially important since it is widely accepted that constituents of serum alone are 
capable of inducing many cellular processes including steroidogenesis and prostaglandin 
formation. This serum-free culture system allowed for further study into the effects of 
Lhlike stimulation on prostaglandin F2a secretion by bovine follicular granulosa cells.
Experiments (Chapter II) that were conducted using this serum-free culture system 
provided evidence that bovine granulosa cells are capable of producing large amounts of 
prostaglandin following forskolin stimulation. It is important to note that mural granulosa 
cells are capable of producing prostaglandin F2a at similar in vivo times. Prostaglandin 
production was curtailed following the addition of dexamethasone to the medium, 
implicating induction of the COX-2 enzyme in this process. Finally, the results of in vitro 
studies (serum-free cultures of bovine granulosa cells with regulatory agents) closely 
mimicked those observed in vivo, and thereby provide models for the study of the 
molecular mechanisms of COX-2 gene expression.
By demonstrating that high levels of gonadotropins (hCG) are able to induce COX- 
2 production by granulosa cells of human preovulatory follicles before ovulation, as in rats 
and cows, the study performed in Chapter IH demonstrates that the expression of COX-2
121
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is a mechanism that has been conserved across species. This mechanism may have been 
preserved across species to regulate the synthesis of prostaglandins necessary for follicle 
ovulation to occur.
Interestingly, a marked difference in the time course of induction of COX-2 in rats 
and humans suggests that the control of COX-2 gene expression could play a pivotal role 
in defining the normal length of the ovulatory process across species. Moreover, the acute 
induction of COX-2 by gonadotropin in granulosa cells before ovulation remains a unique 
physiological event, during which the molecular mechanisms of COX-2 regulation may be 
readily studied in vivo or in vitro.
The exact mechanisms involved in the process of corpus luteum regression, which 
occurs towards the latter stages of the bovine estrous cycle, still remains unresolved. The 
current belief of the mechanisms involved with luteolysis in cattle still lie in the "old 
school" train of thought that prostaglandin transverses the broad ligament to the ovary and 
enclosed corpus luteum after being released from an estrogen primed uterus. However, 
the founding authors of the "counter current mechanism" themselves have since questioned 
the true physiological relevance of this mechanism. Also, later studies have suggested that 
there is no counter current exchange of prostaglandin from the uterine vein to the ovarian 
artery.
Based on the results of the experiment performed in Chapter IV, it appears unlikely 
that the COX-2 isoform is present in the cells of the uterine endometrium during the period
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of luteolysis. Tissue extracts obtained from the bovine uterus during the luteolytic phase 
of the bovine estrous cycle indicate the absence of the COX-2 isoform at this critical time 
period (days 16,19 and 22 of the bovine estrous cycle). Although the COX-1 isoform was 
noted to be present during this period, no discemable pattern of its production could be 
correlated with luteal regression in individual animals.
With the COX-2 isoform being recently discovered, it has been largely man­
ipulated in unphysiological situations in attempts to quantify and classify its production. 
These studies included situations where the COX-2 isozyme was studied in following 
transfection into Swiss 3T3 and Cos-7 cells. It was the design o f the studies included 
herein to provide a "physiological relevance" of this enzyme to certain reproductive 
processes. Although such studies have been thought to do so, it is important that further 
studies continue along these lines to help resolve the mechanisms involved in prostaglandin 
synthesis and regulation in reproductive and other biological processes.
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